Giuseppe Mancia

Q: What Schools Are Affiliated With Giuseppe Mancia

Giuseppe Mancia is affiliated with the following schools: University of Milan, University of Sydney, University of Valencia, University of Florence, University of Adelaide, University of Milano-Bicocca, Sapienza University of Rome, Harvard University

Giuseppe Mancia's AcademicInfluence.com Rankings

Giuseppe Mancia

Philosophy

#1665

World Rank

#2981

Historical Rank

Logic

#268

World Rank

#558

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Giuseppe Mancia Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giuseppe Mancia's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) (9420)
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
2018 ESC/ESH Guidelines for the management of arterial hypertension. (2018) (5481)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (5476)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension (2003) (2640)
European guidelines on cardiovascular disease and prevention in clinical practice. (2003) (2501)
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). (2003) (2476)
[2018 ESC/ESH Guidelines for the management of arterial hypertension]. (2019) (2445)
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. (2007) (1965)
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement (2003) (1756)
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (2018) (1684)
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. (1999) (1577)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document (2009) (1452)
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. (1998) (1370)
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) (2000) (1208)
European Society of Hypertension position paper on ambulatory blood pressure monitoring. (2013) (1184)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (2013) (1115)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. (2003) (1088)
Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. (2006) (1045)
Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) (2007) (1040)
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. (2004) (1028)
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. (1987) (998)
The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) (2013) (991)
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study (2005) (988)
Comparison of Finger and Intra‐arterial Blood Pressure Monitoring at Rest and During Laboratory Testing (1989) (966)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) (911)
2016 European Guidelines on cardiovascular disease prevention in clinical practice (2012) (904)
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. (1998) (872)
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 (2020) (865)
Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. (1995) (862)
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring (2008) (823)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings (1983) (774)
2013 ESH/ESC Guidelines for the management of arterial hypertension (2013) (754)
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. (2005) (736)
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. (2014) (731)
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. (2005) (719)
EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE (1983) (709)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. (2009) (707)
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure (2006) (666)
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. (2005) (650)
Prognostic value of 24-hour blood pressure variability (1993) (650)
Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? (2006) (625)
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. (1999) (623)
Central blood pressure measurements and antihypertensive therapy: a consensus document. (2007) (612)
Ambulatory blood pressure normality: results from the PAMELA study (1995) (611)
Sympathetic activation in obese normotensive subjects. (1995) (606)
Evaluation of the Baroreceptor‐Heart Rate Reflex by 24‐Hour Intra‐arterial Blood Pressure Monitoring in Humans (1988) (599)
European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) (2003) (592)
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension (2014) (579)
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. (2014) (568)
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy (1997) (566)
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. (1999) (557)
ESH/ESC guidelines for the management of arterial hypertension: how to implement in daily clinical practice (2004) (556)
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. (2016) (544)
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial (2002) (528)
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. (2009) (528)
Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) (2001) (527)
Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. (1998) (516)
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life (2000) (498)
Alerting reaction and rise in blood pressure during measurement by physician and nurse. (1987) (489)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. (2018) (476)
European Society of Hypertension Practice Guidelines for home blood pressure monitoring (2010) (465)
A new approach to analysis of the arterial baroreflex. (1985) (457)
Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. (1988) (429)
Mechanisms Responsible for Sympathetic Activation by Cigarette Smoking in Humans (1994) (384)
Serum uric acid and the risk of cardiovascular and renal disease. (2015) (376)
The sympathetic nervous system and the metabolic syndrome. (2007) (369)
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. (2003) (368)
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. (1998) (367)
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study (2009) (348)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study (2007) (345)
Ambulatory Blood Pressure Monitoring and Organ Damage (2000) (343)
Methods and devices for measuring arterial compliance in humans. (2002) (341)
Persistent blood pressure increase induced by heavy smoking. (1992) (325)
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. (2007) (324)
Blood-pressure control in the hypertensive population (1997) (314)
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives (2004) (309)
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal (2009) (309)
Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (1998) (308)
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites (1997) (304)
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) (2001) (301)
Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension (2000) (288)
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome (2005) (287)
New-onset diabetes and antihypertensive drugs. (2006) (287)
Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension (2010) (285)
[Management of high blood pressure in children and adolescents: Recommendations of the European Society of hypertension]. (2010) (284)
Systolic and diastolic blood pressure control in antihypertensive drug trials. (2002) (282)
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients (2011) (281)
Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure (2011) (274)
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. (2012) (274)
Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension (2009) (274)
Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. (1993) (272)
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. (2012) (267)
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial (2014) (266)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. (1983) (257)
Heart rate as marker of sympathetic activity (1998) (255)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (2018) (254)
Arterial Baroreflexes and Blood Pressure and Heart Rate Variabilities in Humans (1986) (252)
Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. (2001) (251)
Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study (1998) (249)
Changes in albuminuria predict mortality and morbidity in patients with vascular disease. (2011) (247)
The Autonomic Nervous System and Hypertension (2014) (246)
Autonomic modulation of the cardiovascular system during sleep. (1993) (243)
Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. (1998) (243)
Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. (1993) (241)
Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis (2004) (240)
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. (1997) (234)
Weather-Related Changes in 24-Hour Blood Pressure Profile: Effects of Age and Implications for Hypertension Management (2006) (230)
Point: cardiovascular variability is/is not an index of autonomic control of circulation. (2006) (230)
Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). (2002) (230)
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials (2017) (228)
Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis (2007) (226)
Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies (2012) (225)
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy (2008) (224)
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. (2006) (223)
Ambulatory blood pressure monitoring use in hypertension research and clinical practice. (1993) (221)
Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity (2005) (219)
Short- and long-term blood pressure variability: present and future. (2012) (218)
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study (2003) (217)
2007 ESH–ESC practice guidelines for the management of arterial hypertension (2008) (217)
Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus (1997) (216)
Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. (1997) (214)
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). (2004) (212)
Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep (1997) (207)
Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey (2002) (206)
Seasonal variations in home and ambulatory blood pressure in the PAMELA population (1998) (204)
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). (2008) (202)
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension (2012) (200)
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. (1998) (200)
Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials (2016) (198)
A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall (2007) (195)
Recommendations for the management of patients with obstructive sleep apnoea and hypertension (2013) (193)
International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. (2003) (191)
Physical training and baroreceptor control of sympathetic nerve activity in humans. (1994) (190)
Heart rate-dependence of arterial distensibility in vivo (1996) (189)
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2009) (187)
Increased serum ferritin is common in men with essential hypertension (2002) (185)
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects. (1995) (184)
Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. (1997) (184)
Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study (2007) (182)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Baroreceptor Reflexes in Human Hypertension (1978) (181)
Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. (2011) (180)
Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension (2015) (176)
Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT) (2003) (175)
Ten Commandments of the 2018 ESC/ESH HTN Guidelines on Hypertension in Adults. (2018) (175)
[Blood pressure variability]. (2001) (174)
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial (2006) (165)
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
Better compliance to antihypertensive medications reduces cardiovascular risk (2011) (163)
Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. (1991) (161)
Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction (2009) (159)
Difference between clinic and daytime blood pressure is not a measure of the white coat effect. (1998) (159)
Clinical value of ambulatory blood pressure: evidence and limits. (2015) (157)
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values (2009) (156)
Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS—A Randomized Double-Blind Trial (2004) (154)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. (2002) (151)
Isobaric compliance of the radial artery is increased in patients with essential hypertension (1993) (150)
An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects. (2016) (150)
Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice (2010) (149)
White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? (1996) (149)
Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. (1992) (149)
Task force V: White-coat hypertension (1999) (148)
Adrenergic, Metabolic, and Reflex Abnormalities in Reverse and Extreme Dipper Hypertensives (2008) (147)
Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. (1990) (147)
Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database (1994) (146)
The variable-pressure neck-chamber method for studying the carotid baroreflex in man. (1977) (146)
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry (2019) (142)
Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study (2009) (140)
Blood Pressure Monitoring. Task force V: White-coat hypertension. (1999) (140)
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study (2014) (140)
Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. (1998) (140)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
The metabolic syndrome in hypertension: European society of hypertension position statement (2008) (138)
Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. (1985) (138)
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. (2013) (138)
Effects of cigarette smoking on carotid and radial artery distensibility (1997) (137)
Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) (2018) (137)
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks (2018) (137)
Lack of placebo effect on ambulatory blood pressure. (1995) (137)
Short- and Long-Term Neuroadrenergic Effects of Moderate Dietary Sodium Restriction in Essential Hypertension (2002) (137)
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) (2011) (136)
Long-Term Prognostic Value of White Coat Hypertension: An Insight From Diagnostic Use of Both Ambulatory and Home Blood Pressure Measurements (2013) (135)
Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study (2004) (134)
Circulatory reflexes from carotid and extracarotid baroreceptor areas in man. (1977) (134)
Blood pressure control in Italy: results of recent surveys on hypertension (2007) (133)
Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations (1998) (132)
Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions – Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability (2016) (132)
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. (2011) (131)
The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction (2005) (131)
Home blood pressure monitoring (2005) (131)
2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. (2021) (131)
Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects. (1999) (130)
The role of blood pressure variability in end-organ damage (2003) (130)
Early impairment of large artery structure and function in Type I diabetes mellitus (1999) (130)
1 – Cardiovascular Regulation during Sleep (1982) (127)
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry (2016) (125)
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis (2008) (124)
Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. (1997) (124)
Cardiopulmonary Reflex Before and After Regression of Left Ventricular Hypertrophy in Essential Hypertension (1988) (123)
Neurogenic Abnormalities in Masked Hypertension (2007) (122)
Baseline Values but Not Treatment-Induced Changes in Carotid Intima-Media Thickness Predict Incident Cardiovascular Events in Treated Hypertensive Patients: Findings in the European Lacidipine Study on Atherosclerosis (ELSA) (2009) (122)
Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima–media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study (2001) (121)
Role of sinoaortic afferents in modulating BP and pulse-interval spectral characteristics in unanesthetized cats. (1991) (121)
Smoking impairs baroreflex sensitivity in humans. (1997) (121)
Seasonal Blood Pressure Changes: An Independent Relationship With Temperature and Daylight Hours (2013) (120)
Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice (2011) (119)
HIV and Metabolic Syndrome: A Comparison With the General Population (2007) (119)
Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms (2007) (117)
Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. (1997) (117)
Visit-to-Visit Blood Pressure Variability, Carotid Atherosclerosis, and Cardiovascular Events in the European Lacidipine Study on Atherosclerosis (2012) (117)
Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects (1995) (116)
Prevalence of Left Ventricular Hypertrophy in Hypertensive Patients Without and With Blood Pressure Control: Data From the PAMELA Population (2002) (116)
Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure: A World Heart Federation Roadmap. (2015) (116)
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. (1990) (113)
Arterial stiffness. (1999) (113)
Treatment of Isolated Systolic Hypertension: The SHELL Study Results (2003) (112)
Sympathetic activation in congestive heart failure. (1990) (112)
Björn Folkow Award Lecture The sympathetic nervous system in hypertension (1997) (112)
Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project (2014) (112)
Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. (2004) (112)
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. (2012) (111)
Sympathetic modulation of radial artery compliance in congestive heart failure. (1995) (111)
Cardiovascular changes during naturally elicited fighting behavior in the cat. (1969) (110)
Structural and Functional Alterations of Subcutaneous Small Resistance Arteries in Severe Human Obesity (2010) (110)
Continuous inhibition of renin release in dogs by vagally innervated receptors in the cardiopulmonary region. (1975) (109)
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. (2002) (109)
Inhibition of Adrenergic Outflow to Peripheral Blood Vessels by Vagal Afferents from the Cardiopulmonary Region in the Dog (1973) (109)
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension (2009) (108)
Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. (1995) (108)
Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. (1988) (107)
Two novel nonsense mutations of HFE gene in five unrelated italian patients with hemochromatosis. (2000) (107)
Arterial Baroreflexes in Humans (2011) (106)
Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
Relationship of Office, Home, and Ambulatory Blood Pressure to Blood Glucose and Lipid Variables in the PAMELA Population (2005) (105)
Influence of diabetes and type of hypertension on response to antihypertensive treatment. (2000) (105)
Interplay among carotid sinus, cardiopulmonary, and carotid body reflexes in dogs. (1976) (104)
Mechanisms and clinical implications of blood pressure variability. (2000) (104)
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium. (2009) (104)
Non-invasive beat-to-beat blood pressure monitoring: new developments (2003) (104)
Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. (1996) (103)
Vasomotor regulation during sleep in the cat. (1971) (103)
Role of Endothelin-1 in Exposure to High Altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) Study (2006) (103)
Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers (2012) (102)
Early alterations of the baroreceptor control of heart rate in patients with acute myocardial infarction. (1990) (101)
ACE Inhibition Attenuates Sympathetic Coronary Vasoconstriction in Patients With Coronary Artery Disease (1992) (101)
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? (2019) (100)
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. (2004) (100)
The Framingham prediction rule is not valid in a European population of treated hypertensive patients (2002) (100)
Impact of Body Mass Index and Waist Circumference on the Long-Term Risk of Diabetes Mellitus, Hypertension, and Cardiac Organ Damage (2011) (100)
24 h sequential spectral analysis of arterial blood pressure and pulse interval in free-moving subjects (1989) (100)
Impact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk: The MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project (2012) (100)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Sympathetic and reflex alterations in systo‐diastolic and systolic hypertension of the elderly (2000) (98)
Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study (2005) (98)
Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study (2006) (97)
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP (2006) (97)
Blood pressure variability in man: its relation to high blood pressure, age and baroreflex sensitivity. (1980) (97)
Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus (2012) (97)
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. (2020) (96)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
Daytime sleepiness and neural cardiac modulation in sleep‐related breathing disorders (2008) (95)
Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment (2012) (94)
Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. (2004) (93)
International Society of Hypertension (ISH): Statement on Blood Pressure Lowering and Stroke Prevention (2003) (93)
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. (2010) (93)
Acute effects of smoking on radial artery compliance in humans (1994) (92)
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. (2009) (92)
Blood pressure variability and organ damage. (1994) (92)
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial. (2014) (91)
Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients (2003) (91)
Relation of cardiovascular changes in fighting to emotion and exercise * (1971) (91)
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
Looking back, looking forward (2004) (91)
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Pro Side of the Argument (2014) (90)
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. (2011) (89)
Reference values for the ambulatory blood pressure and the blood pressure measured at home: a population study. (1991) (89)
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. (1998) (89)
Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. (2002) (88)
Coronary artery disease in Africa and the Middle East (2012) (88)
Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study (2016) (88)
Ethnic Differences in the Degree of Morning Blood Pressure Surge and in Its Determinants Between Japanese and European Hypertensive Subjects: Data From the ARTEMIS Study (2015) (88)
Control of blood pressure by carotid sinus baroreceptors in human beings. (1979) (88)
Modification of arterial baroreflexes by captopril in essential hypertension. (1982) (87)
Muscle and skin sympathetic nerve traffic during the "white-coat" effect. (1999) (87)
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. (2016) (87)
Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. (2004) (86)
Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension (2012) (86)
Reflex control of the human cardiovascular system. (1986) (86)
Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. (2014) (86)
Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication (2016) (86)
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection (2005) (86)
A new method for evaluating the baroreflex role by a joint pattern analysis of pulse interval and systolic blood pressure series. (1985) (86)
Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study (2014) (85)
Midwall Mechanics Are Improved After Regression of Hypertensive Left Ventricular Hypertrophy and Normalization of Chamber Geometry (2001) (85)
Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. (1999) (85)
Heart rate-dependent stiffening of large arteries in intact and sympathectomized rats. (1999) (83)
Digitalis and Baroreceptor Reflexes in Man (1981) (83)
Diagnosis and management of patients with white-coat and masked hypertension (2011) (82)
Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. (2009) (81)
Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications (2015) (81)
Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: implications for studies on antihypertensive drugs (1992) (81)
Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension (1998) (81)
24-hour blood pressure monitoring: evaluation of Spacelabs 5300 monitor by comparison with intra-arterial blood pressure recording in ambulant subjects. (1988) (80)
Effects of Heart Rate Changes on Arterial Distensibility in Humans (2003) (80)
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? (2009) (80)
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials. (2011) (80)
Cardiovascular regulation during sleep. (1982) (80)
Impairment of Thermoregulatory Control of Skin Sympathetic Nerve Traffic in the Elderly (2003) (79)
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. (2010) (79)
Fluctuations of radial artery distensibility throughout the menstrual cycle. (1999) (79)
Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the ‘white‐coat’ effect (1998) (79)
Mechanisms of hypertension in the cardiometabolic syndrome (2009) (79)
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials (2018) (78)
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes (2016) (78)
Job Strain and Blood Pressure in Employed Men and Women: A Pooled Analysis of Four Northern Italian Population Samples (2003) (77)
Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: An updated review (2017) (77)
Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE (2009) (77)
Hypertension and sexual dysfunction: time to act. (2011) (76)
Local Effects of Atherosclerotic Plaque on Arterial Distensibility (2001) (76)
Decreased cardiopulmonary reflexes with aging in normotensive humans. (1989) (76)
Progression of large artery structural and functional alterations in Type I diabetes (2001) (75)
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. (2013) (75)
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results (2008) (75)
High‐altitude hypoxia and periodic breathing during sleep: gender‐related differences (2013) (75)
The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes (2014) (75)
Influence of Carotid Baroreceptors on Vascular Responses to Carotid Chemoreceptor Stimulation in the Dog (1975) (74)
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk (2015) (74)
Dynamic Modulation of Baroreflex Sensitivity in Health and Disease (2001) (74)
Statins and primary liver cancer: a meta-analysis of observational studies (2013) (74)
Total Cardiovascular Risk, Blood Pressure Variability and Adrenergic Overdrive in Hypertension: Evidence, Mechanisms and Clinical Implications (2012) (73)
Effect of placebo on 24-h non-invasive ambulatory blood pressure. (1991) (73)
Blood pressure measurement in research and in clinical practice: recent evidence (2004) (73)
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima–media thickness (2007) (73)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension (2009) (73)
New developments in the pathogenesis of obesity-induced hypertension. (2015) (72)
Daily Life Blood Pressure Changes Are Steeper in Hypertensive Than in Normotensive Subjects (2003) (72)
Blood Pressure Variability and Organ Damage in a General Population: Results from the PAMELA Study (2002) (72)
The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. (2017) (72)
Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials (2010) (72)
Acute Effect of High-Fat Meal on Endothelial Function in Moderately Dyslipidemic Subjects (2004) (72)
Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis (2007) (71)
Untreated Masked Hypertension and Subclinical Cardiac Damage: A Systematic Review and Meta-analysis. (2015) (71)
Angiotensin–sympathetic system interactions in cardiovascular and metabolic disease (2006) (70)
Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study (2001) (70)
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events (2010) (69)
Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. (2016) (69)
White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis (2015) (69)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. (2014) (69)
Arterial distensibility in humans. Modulating mechanisms, alterations in diseases and effects of treatment. (2002) (69)
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes (2017) (69)
Sympathetic activity, blood pressure variability and end organ damage in hypertension. (1997) (69)
Effect of isometric hand-grip exercise on the carotid sinus baroreceptor reflex in man. (1978) (69)
Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial (2013) (68)
Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours (2008) (67)
Effects of Slow Deep Breathing at High Altitude on Oxygen Saturation, Pulmonary and Systemic Hemodynamics (2012) (67)
Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension (1992) (67)
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS) (2004) (67)
Updated ESH position paper on interventional therapy of resistant hypertension. (2013) (67)
Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care (2004) (66)
Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. (1997) (66)
Effects of graded vasoconstriction upon the measurement of finger arterial pressure. (1992) (66)
Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. (2010) (66)
Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure. (1998) (66)
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study (2007) (66)
Increase in blood pressure reproducibility by repeated semi‐automatic blood pressure measurements in the clinic environment (1994) (66)
Advancements in estimating baroreflex function. (2001) (66)
The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes (2013) (66)
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses (2018) (65)
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population (2008) (65)
Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review (2012) (65)
Role of Cardiac, Pulmonary, and Carotid Mechanoreceptors in the Control of Hind‐Limb and Renal Circulation in Dogs (1975) (65)
Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. (2020) (65)
Generating evidence from computerized healthcare utilization databases. (2015) (65)
Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data (2014) (65)
Clinical relevance blood pressure variability. (1998) (64)
Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease (2015) (64)
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study (2013) (64)
Treatment of hypertension: The ESH/ESC guidelines recommendations. (2017) (64)
Age and target organ damage in essential hypertension: role of the metabolic syndrome. (2007) (64)
Nocturnal hypertension and organ damage in dippers and nondippers. (2012) (64)
Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy (2017) (64)
Participation of the Hypothalamus-Hypophysis Axis in the Sympathetic Activation of Human Obesity (2001) (63)
Attenuation of the "white-coat effect" by antihypertensive treatment and regression of target organ damage. (2000) (63)
Reflex cardiovascular control in congestive heart failure. (1992) (63)
Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients (2014) (62)
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009 (2015) (62)
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action (2008) (62)
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. (2013) (62)
Cardiac, Neuroadrenergic, and Portal Hemodynamic Effects of Prolonged Aldosterone Blockade in Postviral Child A Cirrhosis (2005) (62)
Predictors of adverse outcome among patients with hypertension and coronary artery disease. (2006) (62)
COVID‐19 and arterial hypertension: Hypothesis or evidence? (2020) (62)
Simultaneous Measurement of Beat-to-Beat Carotid Diameter and Pressure Changes to Assess Arterial Mechanical Properties (2008) (61)
Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds (2005) (61)
Effect of sinoaortic denervation on frequency-domain estimates of baroreflex sensitivity in conscious cats. (1999) (61)
Ambulatory blood pressure normalcy: the PAMELA Study. (1991) (61)
Adherence With Antihypertensive Drug Therapy and the Risk of Heart Failure in Clinical Practice (2015) (61)
Relationship Among Morning Blood Pressure Surge, 24-Hour Blood Pressure Variability, and Cardiovascular Outcomes in a White Population (2014) (61)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality (2014) (60)
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. (2008) (60)
Broad-band spectral analysis of 24 h continuous finger blood pressure: comparison with intra-arterial recordings. (1999) (60)
Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension (2018) (59)
Efficacy and tolerability profile of nebivolol vs atenolol in mild‐to‐moderate essential hypertension: Results of a double‐blind randomized multicentre trial (2003) (59)
Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial (2010) (59)
Cardiovascular Reflexes and Hypertension (1991) (59)
Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. (1997) (59)
Blood pressure reduction and cardiovascular outcomes: past, present, and future. (2007) (59)
Variability of the haemodynamic responses to laboratory tests employed in assessment of neural cardiovascular regulation in man. (1985) (59)
Prevalence and clinical significance of a greater ambulatory versus office blood pressure (‘reversed white coat’ condition) in a general population (2005) (59)
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study (2014) (59)
Interactions between Sino‐aortic Reflexes and Cardiovascular Effects of Sleep and Emotional Behavior in the Cat (1976) (59)
Inverse relationship between heart rate and blood pressure variabilities in rats. (1987) (58)
Blood pressure variability and its implications for antihypertensive therapy. (1995) (58)
Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. (1990) (58)
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects (2015) (58)
Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) (2012) (58)
Hemodynamic responses to different emotional stimuli in the cat: patterns and mechanisms. (1972) (58)
Inflammatory Activation During Coronary Artery Surgery and Its Dose-Dependent Modulation by Statin/ACE-Inhibitor Combination (2007) (58)
Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus (2012) (58)
Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart failure. (1995) (58)
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects. (1988) (57)
Cardiovascular Effects of an Earthquake: Direct Evidence by Ambulatory Blood Pressure Monitoring (2001) (57)
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial (2016) (57)
1999 WHO/ISH Hypertension Guidelines--highlights & ESH update. (2001) (57)
Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management – is nice always good? (2012) (57)
Blood pressure variability and silent cerebral damage in essential hypertension. (2004) (57)
Short- Versus Long-Term Effects of Different Dihydropyridines on Sympathetic and Baroreflex Function in Hypertension (2003) (57)
Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. (2001) (56)
Sympathetic Neural Overdrive in the Obese and Overweight State. (2019) (56)
Baroreceptor Control of Atrioventricular Conduction in Man (1979) (56)
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial (2014) (55)
Blood pressure variability, cardiovascular risk and antihypertensive treatment (1995) (55)
Neural and Non-neural Mechanisms influencing Circulation during Sleep (1969) (55)
Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database (2010) (55)
An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan (2002) (55)
Baroreflex function in hypertension: consequences for antihypertensive therapy. (2006) (54)
Blood pressure and heart rate variability in autonomic disorders: a critical review (1996) (54)
Absolute and relative changes in carotid intima–media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA) (2004) (54)
Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. (2001) (53)
Prevention and treatment of stroke in patients with hypertension. (2004) (53)
Reflex control of blood pressure and heart rate by arterial baroreceptors and by cardiopulmonary receptors in the unanaesthetized cat. (1985) (53)
Changes in plasma catecholamines in response to reflex modulation of sympathetic vasoconstrictor tone by cardiopulmonary receptors. (1985) (53)
Methods for assessing blood pressure values in humans. (1983) (53)
Sympathectomy and cardiovascular spectral components in conscious normotensive rats. (1995) (53)
An international co-operative study on the relation of blood pressure to electrolyte excretion in populations. I. design and methods (1986) (53)
Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus (2001) (53)
Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. (2007) (53)
Alterations of radial artery compliance in patients with congestive heart failure. (1995) (52)
Prognostic value of long-term blood pressure variability: the evidence is growing. (2011) (52)
Dynamic adaptation of cardiac baroreflex sensitivity to prolonged exposure to microgravity: data from a 16-day spaceflight. (2008) (52)
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH) (2017) (52)
Radial artery compliance in young, obese, normotensive subjects. (1995) (52)
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studie (2012) (51)
Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study (2018) (51)
Antihypertensive treatment: past, present and future. (1998) (51)
Combined effects of hypertension and hypercholesterolemia on radial artery function. (1997) (51)
Cigarette smoking and the adrenergic nervous system. (1992) (51)
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: A retrospective analysis of 50 studies (2008) (51)
The first report of the Systolic and Pulse Pressure (SYPP) Working Group. (1999) (51)
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states (2015) (51)
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study (2017) (51)
Reflex control of circulation by heart and lungs. (1976) (50)
Plasma catecholamines do not invariably reflect sympathetically induced changes in blood pressure in man. (1983) (50)
Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy (2015) (50)
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. (2013) (50)
Two-Drug Combinations as First-Step Antihypertensive Treatment. (2019) (50)
Lacidipine and Blood Pressure Variability in Diabetic Hypertensive Patients (2000) (50)
Regulation of renal circulation during behavioral changes in the cat. (1974) (50)
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study (2012) (49)
Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients (2007) (49)
Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients. (1994) (49)
Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial (2012) (49)
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. (2011) (49)
Assessment of overall blood pressure variability and its different components (2003) (48)
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. (2014) (48)
Ambulatory pressure decreases on long‐term placebo treatment in older patients with isolated systolic hypertension (1994) (48)
Validity and usefulness of non-invasive ambulatory blood pressure monitoring. (1985) (48)
Job strain and ambulatory blood pressure levels in a population-based employed sample of men from northern Italy. (1996) (48)
Tolerability and treatment compliance with angiotensin II receptor antagonists. (2003) (48)
Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertension (2010) (47)
Broadband spectral analysis of blood pressure and heart rate variability in very elderly subjects. (1997) (47)
Effects of venesections and restricted diet in patients with the insulin‐resistance hepatic iron overload syndrome (2004) (47)
Radial Artery Flow-Mediated Dilatation in Heart Failure Patients: Effects of Pharmacological and Nonpharmacological Treatment (2001) (46)
Blood pressure control by the nifedipine GITS–telmisartan combination in patients at high cardiovascular risk: the TALENT study (2011) (46)
High-altitude exposure of three weeks duration increases lung diffusing capacity in humans. (2011) (46)
Blood pressure variability as a risk factor (2001) (46)
Device-Guided Paced Breathing in the Home Setting: Effects on Exercise Capacity, Pulmonary and Ventricular Function in Patients With Chronic Heart Failure: A Pilot Study (2008) (46)
Cardiopulmonary Baroreflexes in Humans (2011) (46)
Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy (2016) (46)
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea (2010) (46)
Hypertension in people with Type 2 diabetes: knowledge‐based diabetes‐specific guidelines (2003) (46)
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population (2013) (46)
Enhanced baroreceptor control of the cardiovascular system by polyunsaturated Fatty acids in heart failure patients. (2006) (46)
Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys (2015) (45)
Clinical trials with ambulatory blood pressure monitoring: fewer patients needed? (1994) (45)
The centenary of blood pressure measurement:a tribute to Scipione Riva‐Rocci (1996) (45)
Large and medium sized artery abnormalities in untreated and treated hypothyroidism. (1997) (45)
Arterial Stiffening Influence of Sympathetic Nerve Activity: Evidence From Hand Transplantation in Humans (2005) (45)
Effect of Long-Term Antihypertensive Treatment on White-Coat Hypertension (2014) (45)
Blood Pressure Non-Dipping and Obstructive Sleep Apnea Syndrome: A Meta-Analysis (2019) (45)
Renal Denervation in High-Risk Patients With Hypertension. (2020) (45)
Sympathetic Mechanisms, Organ Damage, and Antihypertensive Treatment (2011) (45)
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? (2020) (44)
Time trends of major coronary risk factors in a northern Italian population (1986-1994). How remarkable are socioeconomic differences in an industrialized low CHD incidence country? (2001) (44)
Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study. (1998) (44)
Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. (2019) (44)
Difference between office and ambulatory blood pressure and response to antihypertensive treatment (1996) (44)
The sympathetic nervous system in human hypertension. (2000) (44)
Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study. (2015) (44)
Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension (2018) (44)
2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy (2013) (44)
Are generic and brand-name statins clinically equivalent? Evidence from a real data-base. (2014) (44)
Ambulatory and Home Blood Pressure Normality: The Pamela Study (1994) (44)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence (2014) (44)
Blood pressure control in hypertension. Pros and cons of available treatment strategies. (2017) (43)
Prognostic value of ambulatory blood pressure monitoring. (1994) (43)
The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension. (2017) (43)
European Society of Hypertension position paper on renal denervation 2021. (2021) (43)
Ambulatory blood pressure monitoring does not interfere with the haemodynamic effects of sleep. (1985) (43)
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy (2000) (43)
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age (2007) (43)
Effects of sino-aortic denervation on spectral characteristics of blood pressure and pulse interval variability: a wide-band approach (1996) (43)
Potentiation of the Baroreceptor‐Heart Rate Reflex By Sympathectomy in Conscious Rats (1991) (43)
Sympathetic activation in cardiovascular and renal disease. (2009) (43)
Sustained Sympathoinhibitory Effects of Cardiac Resynchronization Therapy in Severe Heart Failure (2004) (43)
Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk. (2018) (43)
Role of outcome trials in providing information on antihypertensive treatment: importance and limitations. (2006) (42)
Role of heart rate variability in the production of blood pressure variability in man. (1987) (42)
Initial Antihypertensive Treatment Strategies and Therapeutic Inertia: Evidence From a Large Population-Based Cohort (2018) (42)
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice (2012) (42)
Effects of physical training of the dominant arm on ipsilateral radial artery distensibility and structure (2001) (42)
Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage. (2008) (42)
Intra-arterial pressure alterations during tail-cuff blood pressure measurements in normotensive and hypertensive rats. (1990) (42)
Hemodynamic Patterns during Desynchronized Sleep in Intact Cats and in Cats with Sinoaortic Deafferentation (1969) (42)
Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques (2012) (41)
Assessing the sensitivity of spontaneous baroreflex control of the heart: deeper insight into complex physiology. (2004) (41)
Effects of Hematocrit Changes on Flow-Mediated and Metabolic Vasodilation in Humans (2002) (41)
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension. (1986) (41)
Is retinal arteriolar–venular ratio associated with cardiac and extracardiac organ damage in essential hypertension? (2009) (41)
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies (2014) (41)
Systolic blood pressure: an underestimated cardiovascular risk factor. (2002) (41)
Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension (2021) (41)
Task Force Report Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention 1,2 (1998) (41)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON (2017) (41)
Office and 24-h ambulatory blood pressure control by treatment in general practice: the ‘Monitoraggio della pressione ARteriosa nella medicina TErritoriale’ study (2010) (40)
Obesity and the sympathetic nervous system. (1996) (40)
INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment. (1996) (40)
Reversed white-coat hypertension: definition, mechanisms and prognostic implications. (2002) (40)
Assessing the white-coat effect: which blood pressure measurement should be considered? (2006) (40)
Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring. (1990) (40)
Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach. (1996) (40)
Nitric oxide dependent vasodilation in young spontaneously hypertensive rats. (1998) (40)
Cardiovascular Risk Associated With White-Coat Hypertension: Pro Side of the Argument. (2017) (40)
Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. (2005) (40)
Changes in Subendocardial Viability Ratio With Acute High-Altitude Exposure and Protective Role of Acetazolamide (2013) (39)
Effects of Prazosin on Autonomic Control of Circulation in Essential Hypertension (1980) (39)
Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice (2004) (39)
Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT) (2002) (39)
Cardiovascular Changes during Preparation for Fighting Behaviour in the Cat (1968) (39)
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study (2014) (39)
Hemodilution reduces clinic and ambulatory blood pressure in polycythemic patients. (1998) (39)
Alterations in cardiac parasympathetic function in aged rats. (1991) (39)
Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures (2010) (38)
Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road? (2005) (38)
Non-Dipping Pattern and Subclinical Cardiac Damage in Untreated Hypertension: A Systematic Review and Meta-Analysis of Echocardiographic Studies. (2015) (38)
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension* (2017) (38)
Rationale for the use of a fixed combination in the treatment of hypertension (1999) (38)
Evaluating sympathetic activity in human hypertension (1993) (38)
Effects of cardiac denervation on blood pressure and heart rate during natural sleep in the cat. (1968) (38)
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2018) (38)
Physical exercise in essential hypertension. (1992) (38)
Blood pressure monitoring: theory and practice. European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability Teaching Course Proceedings. (2017) (38)
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) (2011) (38)
Cardiopulmonary receptor reflexes in normotensive athletes with cardiac hypertrophy. (1990) (38)
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies (2015) (38)
Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers (2008) (38)
Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study (2019) (37)
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials (2009) (37)
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude (2011) (37)
Differential effects of aging on the heart rate and blood pressure influences of arterial baroreceptors in awake rats. (1991) (37)
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (37)
Similarity between generic and brand‐name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population‐based study (2014) (37)
Neural Cardiovascular Regulation and 24‐Hour Blood Pressure and Heart Rate Variability (1996) (37)
Metabolic syndrome and biventricular hypertrophy in essential hypertension (2009) (37)
Coronavirus disease 2019 and cardiovascular complications: focused clinical review (2021) (37)
Limited reproducibility of MUCH and WUCH: evidence from the ELSA study. (2020) (37)
Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height2.7 (2009) (37)
Increased Arterial Stiffness in Normoglycemic Normotensive Offspring of Type 2 Diabetic Parents (2008) (37)
European Society of Hypertension position paper on renal denervation 2018. (2018) (37)
Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension (2015) (37)
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. (2019) (37)
Cardiac and vascular structural changes in normotensive subjects with parental hypertension (1995) (37)
Essential hypertension and the sympathetic nervous system (2008) (37)
Sympathetic Nervous System, Sleep, and Hypertension (2018) (36)
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction (2015) (36)
Long-term use of statins reduces the risk of hospitalization for dementia. (2013) (36)
Gender differences in the association between education and the incidence of cardiovascular events in Northern Italy. (2011) (36)
Medication persistence and the use of generic and brand-name blood pressure-lowering agents (2014) (36)
INVEST revisited: review of findings from the International Verapamil SR–Trandolapril Study (2009) (36)
The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg (2016) (36)
Effects of isolated systolic hypertension and essential hypertension on large and middle-sized artery compliance. (1998) (36)
New year, new challenges. (2003) (36)
Coping with the challenges of the next four years (2002) (36)
Blood pressure variability at normal and high blood pressure. (1983) (36)
Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class (2011) (36)
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial (2017) (36)
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis (2001) (35)
The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines. (2008) (35)
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study (2010) (35)
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial (2016) (35)
Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. (1991) (35)
Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis (2014) (35)
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes (2016) (35)
Systolic blood pressure and pulse pressure: role of 24-h mean values and variability in the determination of organ damage. (1999) (35)
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study. (2013) (34)
Neurogenic hypertension: is the enigma of its origin near the solution? (2004) (34)
The importance of blood pressure variability in hypertension. (2000) (34)
Effect of stress on diagnosis of hypertension. (1991) (34)
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. (1989) (34)
Body mass index, nocturnal fall in blood pressure and organ damage in untreated essential hypertensive patients (2008) (34)
The metabolic syndrome: a critical appraisal based on the CUORE epidemiologic study. (2009) (34)
Associations between body mass index and the risk of renal events in patients with type 2 diabetes (2018) (34)
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases. (2011) (34)
Arterial baroreceptor control of blood pressure in man. (1984) (34)
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: the Pamela study (2015) (34)
Ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs (1994) (33)
Central and Reflex Regulation of Sympathetic Vasoconstrictor Activity to Limb Muscles during Desynchronized Sleep in the Cat (1974) (33)
Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (33)
Clonidine and Carotid Baroreflex in Essential Hypertension (1979) (33)
Untreated masked hypertension and carotid atherosclerosis: A meta-analysis (2015) (33)
Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients (2010) (33)
Metabolic syndrome in human immunodeficiency virus-positive subjects: prevalence, phenotype, and related alterations in arterial structure and function. (2013) (33)
Medical treatment of stable angina: A tailored therapeutic approach. (2016) (32)
Blood pressure variability: clinical implications and effects of antihypertensive treatment. (1994) (32)
Unobserved automated office blood pressure measurement in the Systolic Blood Pressure Intervention Trial (SPRINT): systolic blood pressure treatment target remains below 140 mmHg. (2016) (32)
Quality control of B-mode ultrasonic measurement of carotid artery intima–media thickness: the European Lacidipine Study on Atherosclerosis (2005) (32)
High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population (2019) (32)
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets (2016) (32)
Early diagnosis of diabetic autonomic neuropathy: present and future approaches (1997) (32)
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy (2012) (32)
Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the arguement. (2014) (32)
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up (2018) (32)
Total cardiovascular risk: a new treatment concept (2006) (31)
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: data from HIGHCARE study on Mount Everest. (2016) (31)
Mechanisms of blood pressure variability in man. (1985) (31)
Optimal control of blood pressure in patients with diabetes reduces the incidence of macro and microvascular events (2007) (31)
Clinical use of ambulatory blood pressure monitoring. (1989) (31)
Role of the Sympathetic Nervous System in Hypertension and Hypertension-Related Cardiovascular Disease (2014) (31)
Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension (2009) (31)
Protective effects of antihypertensive treatment in patients aged 85 years or older (2017) (31)
Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study (2008) (31)
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol (2018) (31)
Nutraceuticals and blood pressure control: a European Society of Hypertension position document. (2020) (31)
Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype (2001) (31)
Methodological problems in evaluation of cardiovascular effects of stress in humans. (1991) (31)
Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based study (2009) (31)
Reflex Cardiovascular Regulation in Humans (1985) (31)
Experience with 24-hour ambulatory blood pressure monitoring in hypertension. (1988) (30)
Role of sinoaortic reflexes in hemodynamic patterns of natural defense behaviors in the cat. (1981) (30)
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study (2019) (30)
White coat effect: semantics, assessment and pathophysiological implications (2003) (30)
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. (1998) (30)
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias (2004) (30)
Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease (2004) (30)
How safe are calcium antagonists in hypertension and coronary heart disease? (1996) (30)
Effects of Chronic Clonidine Administration on Sympathetic Nerve Traffic and Baroreflex Function in Heart Failure (2001) (30)
Manual of Hypertension of the European Society of Hypertension, Second Edition (2008) (30)
Sympathetic nerve traffic responses to surgical removal of pheochromocytoma. (1999) (30)
Atrial Natriuretic Factor and Arterial Baroreceptor Reflexes in Unanesthetized Rats (1990) (30)
Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population (2014) (30)
Depression during interferon therapy for chronic viral hepatitis: early identification of patients at risk by means of a computerized test (2000) (30)
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? (2020) (29)
Investigating baroreflex control of circulation using signal processing techniques (1997) (29)
Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. (2020) (29)
Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy (2012) (29)
Cardiopulmonary receptor regulation of renin release. (1988) (29)
Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias. (2003) (29)
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy (2007) (29)
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. (2020) (29)
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. (2012) (29)
Continuous positive airway pressure increases haemoglobin O2 saturation after acute but not prolonged altitude exposure. (2010) (29)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. (2016) (29)
The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity–mortality trials? (2007) (29)
Effect of sinoaortic denervation on frequency-domain estimates of baroreflex sensitivity in conscious cats. (1999) (29)
Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease. (2000) (28)
Does Estimated Pulse Wave Velocity Add Prognostic Information? (2020) (28)
Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension (2013) (28)
Alpha 1-blocking properties of carvedilol during acute and chronic administration. (1992) (28)
Management of antihypertensive drugs in three European countries (2009) (28)
Vascular inflammation and aortic stiffness relate to early left ventricular diastolic dysfunction in prehypertension (2013) (28)
The old Editors' new prologue (2000) (28)
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction (2019) (28)
Relationship between arterial distensibility and coronary atherosclerosis in angina patients (2007) (28)
Effect of sympathectomy on blood pressure variability in the conscious rat. (1991) (28)
Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients (2011) (27)
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population (2017) (27)
Influence of smoking on baroreceptor function: 24 h measurements. (1999) (27)
Assessment of Target Organ Damage in the Evaluation and Follow‐Up of Hypertensive Patients: Where Do We Stand? (2013) (27)
Hypertension and COVID-19: Ongoing Controversies (2021) (27)
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis. (2019) (27)
DOES THE BARORECEPTOR‐HEART RATE REFLEX INDICATE THE CAPACITY OF THE ARTERIAL BARORECEPTORS TO CONTROL BLOOD PRESSURE? (1980) (27)
Sleep apnoea and hypertension (2002) (27)
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: data from the PAMELA population. (2014) (27)
Low anthracyclines doses‐induced cardiotoxicity in acute lymphoblastic leukemia long‐term female survivors (2010) (27)
Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study (2005) (27)
Effect of ageing on blood pressure variability. (1991) (27)
Improving long-term prediction of first cardiovascular event: the contribution of family history of coronary heart disease and social status. (2014) (26)
Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. (2000) (26)
Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients (2017) (26)
1999 WHO/ISH hypertension guidelines--highlights and esh update. (2001) (26)
Sympathomoderating influence of benazepril in essential hypertension (1992) (26)
Hyperuricemia, urate deposition and the association with hypertension (2015) (26)
The Heterogeneous Nature of White-Coat Hypertension. (2016) (26)
Sympathetic Response to Ventricular Extrasystolic Beats in Hypertension and Heart Failure (2002) (26)
Blood pressure monitoring over short day and night times cannot predict 24-hour average blood pressure. (1985) (26)
Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies (2015) (26)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project (2020) (26)
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement (2013) (26)
Nondipping pattern and carotid atherosclerosis: a systematic review and meta-analysis (2016) (26)
How to improve the assessment of 24-h blood pressure variability (2005) (26)
Alterations in neural cardiovascular control mechanisms with ageing. (1994) (26)
Noninvasive automatic blood pressure monitoring does not attenuate nighttime hypotension. Evidence from 24 h intraarterial blood pressure monitoring. (1992) (26)
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure (2009) (25)
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories (2020) (25)
Lack of autonomic contributions to tonic nitric oxide‐mediated vasodilatation in unanesthetized free‐moving rats (1998) (25)
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation (2020) (25)
Left atrial function in elite athletes: A meta‐analysis of two‐dimensional speckle tracking echocardiographic studies (2019) (25)
Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea) (2016) (25)
Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome. (2009) (25)
Impairment of the arterial baroreflex during symptomatic and silent myocardial ischemia in humans. (1993) (25)
Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension (2004) (25)
Blood pressure reduction and end‐organ damage in hypertension (1994) (25)
Critical Appraisal of Indices for the Assessment of Baroreflex Sensitivity (1997) (25)
Effects of Cancer Therapy Targeting Vascular Endothelial Growth Factor Receptor on Central Blood Pressure and Cardiovascular System. (2016) (24)
Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Italy. (2018) (24)
White coat effect and white coat hypertension: What do they mean? (2003) (24)
White Coat Hypertension: to Treat or Not to Treat? (2016) (24)
Diagnostic and therapeutic problems of isolated systolic hypertension. (2015) (24)
Methods to quantify sympathetic cardiovascular influences. (1998) (24)
Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients (2006) (24)
Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension (2015) (24)
Plasma catecholamines and blood pressure responses to the carotid baroreceptor reflex in essential hypertension. (1979) (24)
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? (2007) (24)
The Pamela Study: Main Findings and Perspectives (2013) (24)
Factors influencing the carotid baroreceptor response to pressure changes in a neck chamber. (1976) (24)
24-hour blood pressure profile in centenarians (2002) (24)
Cardiopulmonary receptor reflex in hypertension. (1988) (23)
Relationship between blood pressure measured in the clinic and by ambulatory monitoring and left ventricular size as measured by electrocardiogram in elderly patients with isolated systolic hypertension (1993) (23)
The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation. (2012) (23)
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: findings from the BP-CARE study (2015) (23)
The kidney and cardiovascular risk – Implications for management: A consensus statement from the European Society of Hypertension (2007) (23)
Evaluation of arterial compliance in humans. (1996) (23)
Reference values for ambulatory blood pressure: a population study. (1991) (23)
Survival Benefits of Different Antiadrenergic Interventions in Pressure Overload Left Ventricular Hypertrophy/Failure (2006) (23)
Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies (2021) (23)
Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice. (2017) (23)
Sex differences in the adherence of antihypertensive drugs: a systematic review with meta-analyses (2020) (23)
Effective ambulatory blood pressure control in medical practice: good news to be taken with caution. (2007) (23)
European Society of Hypertension Scientific Newsletter: clinical value of ambulatory blood pressure monitoring (2006) (23)
Clinical Significance of “White Coat” Hypertension (1990) (23)
Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. (2014) (23)
Carotid Sinus Baroreceptor Control of Arterial Pressure in Renovascular Hypertensive Subjects (1982) (23)
Influence of cardiopulmonary receptors on the bradycardic responses to carotid baroreceptor stimulation in man. (1987) (23)
The sympathetic nervous system in human hypertension. (1997) (22)
Analysis of heart rate and blood pressure variability in the assessment of autonomic regulation in arterial hypertension. (1996) (22)
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis (2021) (22)
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report (2017) (22)
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea (2014) (22)
Methyldopa and neural control of circulation in essential hypertension. (1980) (22)
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine (2015) (22)
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes. (1983) (22)
Antihypertensive treatment and new-onset diabetes mellitus (2005) (22)
Nocturnal blood pressure in untreated essential hypertensives (2011) (22)
Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. (2021) (22)
The Un-Observed Automated Office Blood Pressure Measurement Technique Used in the SPRINT Study Points to a Standard Target Office Systolic Blood Pressure <140 mmHg (2017) (22)
Changes in arterial compliance induced by physical training in hammer‐throwers (1992) (22)
Considerations on current and future trials in hypertension. (1996) (22)
Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs. (2000) (22)
Task force II: Ambulatory blood pressure monitoring in population studies. (1999) (21)
Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers (2020) (21)
Evaluation of the antihypertensive effect of celiprolol by ambulatory blood pressure monitoring. (1988) (21)
Blood Pressure and Organ Damage (1987) (21)
Effects of the Combination of Low-Dose Nifedipine GITS 20 mg and Losartan 50 mg in Patients with Mild to Moderate Hypertension (2004) (21)
Prognostic value of left ventricular mass normalized to different body size indexes: findings from the PAMELA population (2015) (21)
Importance of Smooth and Sustained Blood Pressure Control in Preventing Cardiovascular Morbidity and Mortality (2001) (20)
Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans. (1989) (20)
Night-time heart rate nondipping: clinical and prognostic significance in the general population (2018) (20)
Reproducibility of beat-by-beat blood pressure and heart rate variability (2001) (20)
Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials. (2020) (20)
Effects of Isometric Exercise on the Carotid Baroreflex in Hypertensive Subjects (1982) (20)
The unappreciated importance of blood pressure in recent and older atrial fibrillation trials (2013) (20)
Twenty-four hour blood pressure variability: clinical implications. (1992) (20)
The “J Curve” Problem Revisited: Old and New Findings (2010) (20)
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT) (1993) (20)
Cardiac Parasympathetic Hyperresponsiveness in Spontaneously Hypertensive Rats (1992) (20)
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial (2014) (20)
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study (2020) (20)
Effect of somatostatin infusion on peptide YY secretion: studies in the acute and recovery phase of anorexia nervosa and in obesity. (2011) (20)
Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). (1998) (20)
Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies (2018) (20)
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction. (1999) (20)
Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure. (1999) (20)
International Society of Hypertension (ISH): statements on blood pressure and stroke (2003) (20)
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension (2021) (20)
Age related prevalence of severe left ventricular hypertrophy in essential hypertension: Echocardiographic findings from the ETODH study (2012) (20)
Renal Artery Denervation for Treating Resistant Hypertension (2012) (20)
The Effect of Antihypertensive Agents on New-Onset Diabetes Mellitus (2006) (19)
Baroreceptor control of the circulation in man. An update. (1995) (19)
Incident Left Ventricular Hypertrophy in Masked Hypertension. (2019) (19)
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction. (1992) (19)
Effects of nifedipine GITS and diuretics in isolated systolic hypertension - a subanalysis of the INSIGHT study (2004) (19)
White coat effect. Innocuous or adverse phenomenon? (2000) (19)
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure (2016) (19)
Device-Guided Paced Breathing in the Home SettingCLINICAL PERSPECTIVE (2008) (19)
Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring (2006) (19)
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans (1988) (19)
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol. (1984) (19)
Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry (2017) (19)
Structural cardiovascular alterations and blood pressure variability in human hypertension (1995) (19)
Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry (2016) (19)
Review: Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension (2008) (18)
Extreme dipping: is the cardiovascular risk increased? An unsolved issue. (2019) (18)
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. (2002) (18)
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials (2011) (18)
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: the PAMELA study (2017) (18)
Blood pressure control in Italian essential hypertensives treated by general practitioners. (2012) (18)
External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data. (2012) (18)
Hypertension in aortic stenosis: a focused review and recommendations for clinical practice. (2020) (18)
Nutrition and prevention of ischemic stroke: present knowledge, limitations and future perspectives. (2004) (18)
Erratum: European society of hypertension position paper on ambulatory blood pressure monitoring (Journal of Hypertension (2013) 31 (1731-1768)) (2013) (18)
Left and right ventricular structural changes in obese hypertensives (2009) (18)
Vasomotor inhibition in rabbits by vagal nonmedullated fibers from cardiopulmonary area. (1975) (18)
Characteristics of contemporary patients with hypertension and coronary artery disease (2004) (18)
Ambulatory blood pressure monitoring in hypertension. (1993) (18)
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (17)
Exercise Treadmill Testing in Moderate or Severe Aortic Stenosis: The Left Ventricular Correlates of an Exaggerated Blood Pressure Rise (2018) (17)
Heart rate as a sympathetic marker during acute adrenergic challenge (2008) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study (2017) (17)
White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020 (2021) (17)
Cardiovascular consequences of poor compliance to antihypertensive therapy (2011) (17)
Blood pressure variability. Importance in research and in clinical hypertension. (1996) (17)
Pre-hypertension and subclinical cardiac damage: A meta-analysis of echocardiographic studies. (2018) (17)
Treatment of Hypertension and Ischemic Heart Disease (1989) (17)
Update of the position paper on arterial hypertension and erectile dysfunction. (2020) (17)
Electrical carotid baroreceptor stimulation in resistant hypertension. (2010) (17)
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis (2020) (17)
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity. (2009) (17)
Clinical value of blood pressure variability. (1997) (17)
P-62: Efficacy of VIAGRA® (sildenafil citrate) in men with erectile dysfunction and arterial hypertension who are taking multiple antihypertensive treatments (2002) (17)
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension. (1986) (17)
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension. (1992) (17)
Opening remarks: The need to manage risk factors of coronary heart disease (1988) (17)
GH deficiency in adult B-thalassemia major patients and its relationship with IGF-1 production. (2011) (17)
Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications. (2019) (17)
Reproducibility of laboratory tests evaluating neural cardiovascular regulation in man. (1983) (16)
Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population? (2016) (16)
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial (2014) (16)
New therapeutic approaches for resistant hypertension. (2012) (16)
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. (2015) (16)
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients (2014) (16)
Metabolic Syndrome (2015) (16)
Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population (2018) (16)
Early and late sympathetic activation in hypertension. (1998) (16)
Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments. (2012) (16)
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results (2014) (16)
Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME. (2020) (16)
Intensification of medication and glycaemic control among patients with type 2 diabetes – the ADVANCE trial (2014) (16)
Nocturnal hypertension and right heart remodeling (2018) (16)
The International Nifedipine GITS Study of Intervention as a Goal in Hypertension Treatment (INSIGHT) trial. (1998) (16)
Left ventricular geometry, ambulatory blood pressure and extra-cardiac organ damage in untreated essential hypertension (2010) (16)
A new dawn in cardiovascular protection III: The challenge of end-organ protection in high-risk patients - Introduction (2005) (16)
The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension (1994) (16)
Arterial stiffness and COVID‐19: A bidirectional cause‐effect relationship (2021) (16)
Increased pulse wave velocity and not reduced ejection fraction is associated with impaired baroreflex control of heart rate in congestive heart failure (2010) (16)
Introduction to a compendium on hypertension. (2015) (16)
Short-Term and Long-Term Blood Pressure Variability (2012) (16)
Labetalol and 24‐Hour Monitoring of Arterial Blood Pressure in Hypertensive Patients (1981) (16)
Visit-to-Visit Blood Pressure Variability: An Insight Into the Mechanisms. (2016) (16)
Nocturnal Hypertension and Subclinical Cardiac and Carotid Damage: An Updated Review and Meta‐Analysis of Echocardiographic Studies (2016) (16)
1999 WHO/ISH Hypertension Guidelines--highlights & ESH Update. (2003) (16)
Arterial distensibility in cardiovascular diseases. (1998) (15)
Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice. (2009) (15)
Ambulatory blood pressure monitoring in the design of studies on antihypertensive drug efficacy. (1993) (15)
Clinical significance of white-coat hypertension. (2016) (15)
Strategies for antihypertensive treatment decisions: how to assess benefits? (1997) (15)
Clinical significance of diabetes likely induced by statins: Evidence from a large population-based cohort. (2017) (15)
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol. (1983) (15)
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome (2017) (15)
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
Scientists' statement regarding data on the sodium-hypertension relationship and sodium health claims on food labeling. (1997) (15)
Cost-effectiveness of enhancing adherence to therapy with blood pressure-lowering drugs in the setting of primary cardiovascular prevention. (2013) (15)
Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period. (1982) (15)
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial (2008) (15)
Spectral analysis of 24 h blood pressure recordings. (1993) (15)
Coronary response to diving in subjects with mild and severe left coronary artery disease. (1992) (15)
Blood pressure variability and reflex control in the elderly (1995) (15)
Sympathetic, parasympathetic and non‐autonomic contributions to cardiovascular spectral powers in unanesthetized spontaneously hypertensive rats (1995) (15)
Sympathetic overactivity and exercise intolerance in heart failure: a cause-effect relationship. (1999) (15)
Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension. (2010) (15)
Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population (2011) (15)
Long-Term Effects of Radiotherapy on Arterial Stiffness in Breast Cancer Women. (2016) (15)
Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY Registry with follow-up data of 3 years. (2021) (15)
Isolated Nocturnal Hypertension: What Do We Know and What Can We Do? (2020) (15)
Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (15)
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: A gender-based study (2013) (15)
Diurnal blood pressure profile in older patients with isolated systolic hypertension. The SYST-EUR Investigators. (1995) (15)
Specific Blood Pressure Targets for Patients With Diabetic Nephropathy? (2016) (15)
The 2007 ESH/ESC Guidelines for the management of arterial hypertension (2008) (15)
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: a time-integrated analysis (2017) (15)
Sodium--glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new era has already begun. (2021) (15)
Metabolic syndrome and cardiometabolic risk: An update (2009) (15)
A new sphygmomanometer. Sphygmomanometric technique. (1996) (15)
Attenuation of the “ WhiteCoat Effect ” by Antihypertensive Treatment and Regression of Target Organ Damage (2000) (15)
The association between 24-h blood pressure patterns and left ventricular mechanics. (2020) (14)
Ambulatory blood pressure in air traffic controllers. (1998) (14)
Orthostatic hypotension and cardiovascular risk: defining the epidemiological and prognostic relevance. (2010) (14)
Defining blood pressure goals: is it enough to manage total cardiovascular risk? (2009) (14)
Infusion of Escherichia coli Lipopolysaccharide Toxin in Rats Produces an Early and Severe Impairment of Baroreflex Function in Absence of Blood Pressure Changes (2013) (14)
Differential control of blood pressure and heart rate by carotid and aortic baroreceptors in unanaesthetized cats. (1987) (14)
Resistant hypertension: Renal denervation or intensified medical treatment? (2017) (14)
Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
23 ELSA, European Lacidipine Study on Atherosclerosis (1993) (14)
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure (2008) (14)
Reflex control of circulation and angiotensin converting enzyme inhibition in man. (1988) (14)
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis. (2020) (14)
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach (2018) (14)
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients (2017) (14)
Effects of prolonged immobilization of the limb on radial artery mechanical properties. (1998) (14)
Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus (2013) (14)
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT). (1995) (14)
Blood Pressure Lowering Effects of Rimonabant in Obesity‐related Hypertension (2008) (14)
Masked hypertension and echocardiographic left ventricular hypertrophy: an updated overview (2012) (14)
Reduction in estimated stroke risk associated with practice-based stroke-risk assessment and awareness in a large, representative population of hypertensive patients: results from the ForLife study in Italy (2007) (14)
Myocardial strain in hypertension: a meta-analysis of two-dimensional speckle tracking echocardiographic studies (2021) (14)
A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140/90mmHg. (2016) (14)
Elevated heart rate and cardiovascular risk in hypertension. (2021) (14)
Effects of the lercanidipine–enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database (2016) (14)
Assessment of antihypertensive treatment by ambulatory blood pressure (1997) (14)
Index measured at an intermediate altitude to predict impending acute mountain sickness. (2011) (14)
Do other cardiovascular risk factors influence the impact of age on the association between blood pressure and mortality? The MORGAM Project (2014) (14)
Combination of lisinopril and nifedipine GITS Increases Blood Pressure Control Compared with Single Drugs in Essential Hypertensive Patients (2003) (14)
RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure. (1993) (14)
Evaluation of a Slow‐Release Clonidine Preparation by Direct Continuous Blood Pressure Recording in Essential Hypertensive Patients (1981) (14)
Variability in arterial diameter and compliance: compliance modulation reserve (1992) (13)
Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockade (2011) (13)
Vascular aging: shifting the paradigm of risk assessment and reduction in hypertension. (2012) (13)
Current antihypertensive treatment: can we do better? (1999) (13)
Brachial and central blood pressure in HIV-infected subjects (2015) (13)
Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning? (2020) (13)
Special issues in hypertension (2012) (13)
Obstructive sleep apnea and cardiac mechanics: how strain could help us? (2020) (13)
Different effects of antihypertensive treatment on office and ambulatory blood pressure: a meta-analysis (2019) (13)
COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial (2020) (13)
Effectiveness of two‐drug therapy versus monotherapy as initial regimen in hypertension: A propensity score‐matched cohort study in the UK Clinical Practice Research Datalink (2019) (13)
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers (2018) (13)
Diabetic cardiomyopathy: How can cardiac magnetic resonance help? (2020) (13)
The ALLHAT trial: a verdict or a challenge? (2003) (13)
Expertise: no longer a sine qua non for guideline authors? (2017) (13)
Evaluating sources of bias in observational studies. (2021) (13)
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals (2013) (13)
Home blood pressure monitoring: a tool for better hypertension control. (2011) (13)
Nitric Oxide‐Dependent Vasodilation and the Regulation of Arterial Blood Pressure (2001) (13)
Erectile dysfunction and adherence to antihypertensive therapy: Focus on β-blockers. (2020) (13)
Blood pressure variability over 24 hours: its different components and its relationship to the arterial baroreflex (1995) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Arterial stiffness in heart failure patients: dependance on diastolic dysfunction and plasma aldosterone levels (2004) (13)
Cardiovascular disease prevention at the workplace: assessing the prognostic value of lifestyle risk factors and job-related conditions (2018) (13)
Commentary on the revised British Hypertension Society protocol for evaluation of blood pressure measuring devices: a critique of aspects related to 24-hour ambulatory blood pressure measurement. (1993) (13)
The Hyper‐Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice (2008) (12)
Vasovagal syncope with bradycardia during lower body negative pressure in a heart transplant recipient. (1993) (12)
Present and future role of combination treatment in hypertension. (1998) (12)
Evaluation of How Gene-Job Strain Interaction Affects Blood Pressure in the PAMELA Study (2011) (12)
Cardiovascular protection for all individuals at high risk: evidence-based best practice (2008) (12)
One hundred years of auscultatory blood pressure: commemorating N. S. Korotkoff. (2005) (12)
Management of essential hypertension. (2010) (12)
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies. (2020) (12)
Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study. (2014) (12)
Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients (2004) (12)
CENTRAL AND PERIPHERAL SYMPATHETIC ACTIVATION IN HEART FAILURE. (2021) (12)
Left ventricular hypertrophy and the 'cardiogenic reflex' in man (1991) (12)
Pre-hypertension and subclinical carotid damage: a meta-analysis (2018) (12)
Emotion and the cardiovascular system in the cat. (1972) (12)
A Smooth Blood Pressure Control is obtained over 24 h by Delapril in Mild to Moderate Essential Hypertensives (2001) (12)
Prevention of risk factors: beta-blockade and hypertension (2009) (12)
Renal artery stenosis and left ventricular hypertrophy: an updated review and meta-analysis of echocardiographic studies (2017) (12)
Potential therapeutic targets in cirrhotic cardiomyopathy. (2007) (12)
Missing Verification of Source Data in Hypertension Research (2021) (12)
Baroreceptor-heart rate reflex studied in normotensives and essential hypertensives by beat-to-beat analysis of twenty-four-hour blood pressure and heart rate (1987) (12)
Ambulatory blood pressure monitoring in clinical practice. (2002) (12)
Regulation of Circulation During Antihypertensive Treatment with Prazosin (1980) (12)
Left ventricular diastolic dysfunction in newly diagnosed untreated hypertensive patients (2012) (12)
Meta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes. (2001) (12)
Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results. (2019) (12)
Individualization of Antihypertensive Drug Treatment (2013) (12)
The relationship between nighttime hypertension and left atrial function (2017) (11)
NEUROADRENERGIC PROFILE IN PATIENTS WITH RESISTANT HYPERTENSION: 9C.03 (2011) (11)
Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality. (2019) (11)
The Prognostic Effect of Circadian Blood Pressure Pattern on Long-Term Cardiovascular Outcome Is Independent of Left Ventricular Remodeling (2019) (11)
The central sympathetic nervous system in hypertension. (2013) (11)
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues. (2012) (11)
Reflex control of renin release in essential hypertension. (1978) (11)
Association of metabolic syndrome with carotid thickening and plaque in the general population: A meta‐analysis (2018) (11)
Use of intravenous digital subtraction ventriculography in the evaluation of left ventricle volumes and ejection fraction. (1991) (11)
Structural cardiovascular adaptation and the consequences for baroreflexes. (1984) (11)
Treatment of heart failure with fosinopril: an angiotensin converting enzyme inhibitor with a dual and compensatory route of excretion. (1997) (11)
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT (2012) (11)
Left ventricular hypertrophy and sympathetic activity. (1997) (11)
New-onset left atrial enlargement in a general population (2016) (11)
Secondary Hypertension: Sleep Apnea (2007) (11)
Preventing new-onset diabetes in thiazide-treated patients. (2016) (11)
Increased nocturnal heart rate and wave reflection are early markers of cardiovascular disease in Williams–Beuren syndrome children (2015) (11)
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials (2007) (11)
Haemodynamic Alterations Triggered by Blood Pressure Assessments by the Doctor (1982) (11)
[European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice]. (2004) (11)
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis. (2020) (11)
Control of regional circulations by the sino-aortic reflexes during desynchronised sleep in the cat. (1978) (11)
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension. (2016) (11)
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
Effect of detraining on the cardiopulmonary reflex in professional runners and hammer throwers. (1992) (11)
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation. (2018) (11)
Differential alterations of common carotid and femoral artery distensibility in 12‐week‐old spontaneously hypertensive rats (1997) (11)
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study (2015) (11)
Monitoring of sympathetic activity in man: physiology and pharmacology. (1992) (11)
New drugs for the treatment of hypertension. (1999) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Left ventricular geometry and diastolic function in the hypertensive heart: Impact of age (2013) (10)
Extreme Dipping : Always means Nocturnal Hypotension ? (2019) (10)
SAFETY AND EFFICACY OF AGGRESSIVE BLOOD PRESSURE LOWERING AMONG PATIENTS WITH DIABETES: SUBGROUP ANALYSES FROM THE ONTARGET TRIAL (2009) (10)
Reflex control of circulation in the elderly (2004) (10)
Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient (2010) (10)
Reverse dipping and subclinical cardiac organ damage: a meta-analysis of echocardiographic studies (2021) (10)
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation (2012) (10)
Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime. (2020) (10)
Targeting Concentric Left Ventricular Hypertrophy In Obstructive Sleep Apnea Syndrome. A Meta-Analysis of Echocardiographic Studies. (2019) (10)
White-Coat Hypertension: the Neglected Subgroup in Hypertension (2018) (10)
Ambulatory blood pressure monitoring and antihypertensive treatment. (1992) (10)
The management of the type 2 diabetic patient with hypertension – too late and too little: Suggested improvements (2008) (10)
PROLONGED INTRA-ARTERIAL BLOOD-PRESSURE RECORDING IN DIAGNOSIS OF PHÆOCHROMOCYTOMA (1979) (10)
Editors?? corner: debating the value of absolute versus relative risk (1996) (10)
Cardiovascular Regulation: Basic Considerations (2007) (10)
Correction: Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project (2015) (10)
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction. (2021) (10)
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial (2020) (10)
Coronary vascular reactivity and calcium antagonist therapy in patients with angina. (1994) (10)
Guidelines for the management of hypertension and target organ damage: reply. (2013) (10)
Calcium Antagonists and Neural Control of Circulation in Essential Hypertension (1987) (10)
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines (2019) (10)
Extracardiac organ damage in essential hypertensives with left ventricular concentric remodelling (2010) (10)
Left ventricular hypertrophy detection and body mass index in essential hypertension (2010) (10)
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension. (2015) (10)
Looking back on three years of editorship (1998) (9)
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population (2021) (9)
Carotid sinus reflex control of renin release in hypertensive subjects with high renin secretion. (1981) (9)
Blood pressure lowering in diabetic patients. (2012) (9)
Clinical Differences among Angiotensin II Receptor Antagonists (2001) (9)
Incidence of renal artery damage following percutaneous renal denervation with radio frequency renal artery ablation systems: Review and Meta-Analysis of published reports. (2020) (9)
Left ventricular hypertrophy and abdominal aorta size in essential hypertension (2011) (9)
Cardiogenic reflexes and left ventricular hypertrophy. (1990) (9)
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High AltitudeNovelty and Significance (2015) (9)
Effects of prostaglandin E1α cyclodestrin treatment on endothelial dysfunction in patients with systemic sclerosis (2007) (9)
Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy (2022) (9)
Protective effects of renin–angiotensin blockade beyond blood pressure control (2009) (9)
Antihypertensive Treatment in Elderly Frail Patients (2020) (9)
Baroreflex modulation of the cardiovascular system: new insights from the joint analysis of blood pressure and heart rate signals. (1996) (9)
Decreased adrenergic tone in acromegaly: evidence from direct recording of muscle sympathetic nerve activity (2012) (9)
Clinical value of ambulatory blood pressure monitoring. (1993) (9)
Hypertension in aortic stenosis: relationship with revealed symptoms and functional measures on treadmill exercise. (2019) (9)
Effects of fosinopril and pravastatin on progression of asymptomatic carotid atherosclerosis in hypertension: Results of the Plaque Hypertension Lipid Lowering Italian Study (PHYLLIS) (2003) (9)
Effects of haemodialysis and kidney transplantation on carotid and cardiopulmonary baroreflexes in uraemic patients (1987) (9)
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. (2013) (9)
Systemic Hypertension Induced by Harpagophytum procumbens (devil's claw): A Case Report (2015) (9)
Telemonitoring of Home Blood Pressure Improves Blood Pressure Control in Hypertension: 4a.2 (2004) (9)
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study (2018) (9)
Haemodynamic effects of ACE inhibitors. (1990) (9)
Hypertension: Strengths and limitations of the JNC 8 hypertension guidelines (2014) (9)
When Patients Are Rendered Normotensive (1994) (9)
Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus (2020) (9)
New antidiabetic therapy and HFpEF: light at the end of tunnel? (2021) (9)
Absence of alarm reactions with use of non-invasive blood pressure monitoring devices. (1985) (9)
Antihypertensive Effect of a New Formulation of Slow Release Oxprenolol in Essential Hypertension (1987) (9)
Guidelines for the treatment of hypertension: a commentary (1996) (9)
Evidence-based medicine: an educational instrument or a standard for implementation? (1999) (9)
Third generation calcium antagonists: further developments. (1996) (9)
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation (2021) (9)
Sympathetic control of circulation in hypertension and congestive heart failure. (1998) (9)
Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascites. (1999) (9)
Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients (1996) (9)
TCT-761 Long-term (3-year) safety and effectiveness from the Global SYMPLICITY Registry of renal denervation in a real world patient population with uncontrolled hypertension. (2016) (9)
Performance of the AM-5600 blood pressure monitor: comparison with ambulatory intra-arterial pressure. (1997) (9)
Obstructive sleep apnoea syndrome and left ventricular hypertrophy: a meta-analysis of echocardiographic studies. (2020) (8)
Left atrial volume in elite athletes: A meta‐analysis of echocardiographic studies (2019) (8)
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension. (2019) (8)
Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man. (1985) (8)
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload (2020) (8)
Ambulatory heart rate and target organ damage in never-treated essential hypertensives (2008) (8)
Additional drug treatment in resistant hypertension: need for randomized studies. (2012) (8)
Nutritional recommendations for the prevention of ischemic stroke. (2004) (8)
Improvement in health‐related quality of life after renal sympathetic denervation in real‐world hypertensive patients: 12‐month outcomes in the Global SYMPLICITY Registry (2017) (8)
Arterial distensibility and pulse pressure. Measurements and clinical significance in hypertension. (1999) (8)
Reflex Control of Circulation in Normotensive and Hypertensive Humans (1983) (8)
Cardiorenal syndrome: Mechanisms, risk and treatment (2010) (8)
Prognostic relevance of electrocardiographic Tpeak–Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study (2016) (8)
Baroreceptor reflexes from different vascular areas in animals and man. (1976) (8)
Intensive glucose‐lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial (2019) (8)
Long-term prediction of major coronary or ischaemic stroke event in a low-incidence Southern European population: model development and evaluation of clinical utility (2013) (8)
Twenty‐four hour ambulatory intra‐arterial blood pressure in normotensive and borderline hypertensive subjects (1988) (8)
Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus. (2014) (8)
The neck chamber technique. (1992) (8)
The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? (2013) (8)
Chapter 58 – Hyperadrenergic and Labile Hypertension (2007) (8)
Cardiovascular abnormalities in special conditions of advanced cirrhosis. The circulatory adaptative changes to specific therapeutic procedures for the management of refractory ascites. (2006) (8)
190 Ambulatory and home blood pressure reference values: the Pamela Study (1993) (8)
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension (2022) (8)
Closed-Loop Cardiovascular Interactions and the Baroreflex Cardiac Arm: Modulations Over the 24 h and the Effect of Hypertension (2019) (8)
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique (2008) (8)
Prognostic and Diagnostic Value of Ambulatory Blood Pressure Monitoring (2005) (8)
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects. (2015) (8)
Structure and Function of Large Arteries Second Workshop (1995) (8)
Twenty-four hour blood pressure monitoring and end-organ damage. (1992) (8)
Clinical Management of Resistant Hypertension (2013) (8)
Cardiac and vascular protection: the potential of ONTARGET. (2008) (8)
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation. (2014) (8)
Spontaneous baroreflex sensitivity: From the cardiovascular laboratory to patient's bedside (1997) (8)
Benefit and costs of anti-hypertensive treatment. (1996) (8)
A107: Irbesartan results in superior blood pressure reduction vs valsartan (2000) (8)
Alterations in sympathetic nerve traffic during cigarette-smoking in man: a preliminary report. (1991) (8)
High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis. (2019) (8)
European Society of Hypertension Scientific Newsletter: Update on Hypertension Management: Prevention of type 2 diabetes mellitus with antihypertensive drugs (2006) (8)
Awareness and behaviour of European physicians in relation to microalbuminuria and organ damage: an ESH-endorsed survey (2010) (8)
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study (2016) (7)
Role of cardiopulmonary receptors in reflex control of renin release in man. (1984) (7)
Inotropic drugs of the future * (1982) (7)
Reproducibility of ultrasound assessment of common carotid and femoral artery compliance and distensibility in the anesthetized rat (1995) (7)
Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient? (2018) (7)
White-coat hypertension: growing evidence in favour of its adverse prognostic significance. (2017) (7)
The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes Mellitus (2014) (7)
Renin–Angiotensin–Aldosterone System Is Not Involved in the Arterial Stiffening Induced by Acute and Prolonged Exposure to High Altitude (2017) (7)
The influence of night-time hypertension on left ventricular mechanics. (2017) (7)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines (2022) (7)
Stratification of the risk of developing severe or lethal Covid-19 using a new score from a large Italian population: a population-based cohort study (2021) (7)
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? (2011) (7)
Safety of calcium antagonists (1995) (7)
Early cardiac and vascular structural changes in subjects with parental hypertension (1993) (7)
Blood pressure variability: Methodological aspects, mechanisms and clinical relevance (1996) (7)
Permanent blood pressure control over the 24 h by trandolapril. (1995) (7)
Hypertension staging through ambulatory blood pressure monitoring. (2002) (7)
24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol. (1988) (7)
Should White-Coat Hypertension in Diabetes Be Treated? Pro (2009) (7)
5.27 Metabolic Syndrome and Multiple Organ Damage in Essential Hypertension (2008) (7)
Impact of new clinical trials on recent guidelines on hypertension management (2011) (7)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. (2022) (7)
Strategies to meet the need for long-term data (2016) (7)
Prevalence and correlates of multiple organ damage in referred treated hypertensives: data from the ETODH study (2008) (7)
Annexin A5 in treated hypertensive patients and its association with target organ damage (2017) (7)
Impact of different dipping patterns on left atrial function in hypertension (2020) (7)
Cardiovascular variability is similarly altered in coronary patients with normal left ventricular function and in heart failure patients (2014) (7)
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement (2021) (7)
Lessons to be learned from 24-hour ambulatory blood pressure monitoring. (1996) (7)
Characteristics of hypertension and arterial stiffness in obstructive sleep apnea: A Scandinavian experience from a prospective study of 6408 normotensive and hypertensive patients (2022) (7)
Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial (2016) (7)
The dilemma of placebo controlled studies: scientific evidence, guidelines, ethics and regulatory recommendations. (2009) (7)
Limitations of the tail-cuff method for measuring blood pressure in rats (1986) (7)
Do recent meta-analyses truly prove that treatment with blood pressure-lowering drugs is beneficial at any blood pressure value, no matter how low? A critical review. (2022) (7)
Attempts to improve the selectivity of calcium antagonistic drugs. (1996) (7)
PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
Ambulatory blood pressure in hypertension with particular reference to the kidney. (1997) (7)
Testing the accuracy of blood pressure monitoring devices in ambulatory conditions. (1991) (7)
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial) (2010) (7)
Searching for information from unreported trials--amnesty for the past and prospective meta-analyses for the future. (1998) (7)
Doctor-elicited blood pressure rises at the time of sphygmomanometric blood pressure assessment persist over repeated visits. (1985) (7)
Management of very elderly hypertensives: the HYVET study (2008) (7)
Hemodynamic and neural effects of urapidil and prazosin in essential hypertensives. (1994) (7)
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: the PAMELA study (2016) (7)
Clinic blood pressure, ambulatory blood pressure and cardiac structural alterations in nonagenarians and in centenarians (2012) (7)
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: a microneurographic study. (2016) (7)
Monotherapy vs combination treatments of different complexity: a meta-analysis of blood pressure lowering randomized outcome trials (2021) (6)
Sex-differences in aortic stenosis: Effect on functional capacity and prognosis. (2019) (6)
Effects of long‐term lercanidipine or hydrochlorothiazide administration on hypertension‐related vascular structural changes (2006) (6)
Clinical Use of Ambulatory Blood Pressure Monitoring: A Critical Appraisal (1994) (6)
Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease. (1994) (6)
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe (2021) (6)
Ambulatory blood pressure monitoring in the ELSA study. European Lacidipine Study on Atherosclerosis. (1996) (6)
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension (2010) (6)
Behavioral effects of electrical stimulation of group I muscle afferents in acute thalamic cats. (1968) (6)
COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION (2022) (6)
Do reverse dippers have the highest risk of right ventricular remodeling? (2019) (6)
Carotid atherosclerosis and cardiovascular risk stratification: Role and cost‐effectiveness of echo‐Doppler examination in untreated essential hypertensives (2006) (6)
Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor (2021) (6)
Blood pressures other than the one at the clinic. (1997) (6)
AMBULATORY BLOOD PRESSURE MONITORING. DISUCSSION (1996) (6)
Clinical Benefits of Consistent Reduction in the Daily Blood Pressure of Hypertensive Patients (2000) (6)
Effects of altering the interval between the stimulus and the reflex response in the analysis of the baroreceptor control of the sinus and atrioventricular nodes in man. (1987) (6)
Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): A protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects (1993) (6)
Salt intake and Cardiovascular Disease. (2017) (6)
Hemodynamic effects of once a day administration of combined chlorthalidone and metoprolol slow-release in essential hypertension. (1984) (6)
Relationship Between Office, Home, Ambulatory Blood Pressure and Alterations in Glucose and Lipid Profile in the PAMELA Population: 2.15 (2005) (6)
The role of ambulatory blood pressure monitoring in elderly hypertensive patients. (2000) (6)
Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial (2009) (6)
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people. (2015) (6)
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns. (2020) (6)
Statin treatment reduces the risk of death among elderly frail patients: evidence from a large population-based cohort. (2020) (6)
Cardiovascular Risk Profile in 14 513 Patients with Essential Hypertension Followed by Italian Specialist Physicians (2004) (6)
Assessing effective and balanced twenty-four-hour blood pressure reduction by treatment: methodological aspects. (1999) (6)
Efficacy of antihypertensive treatment: Which endpoints should be considered? (2005) (6)
The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial (2020) (6)
Hypertension, antihypertensive treatment and stroke prevention (2005) (6)
National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities (2014) (6)
Blood Pressure–Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers (2020) (6)
Cardiac hypertrophy impairs cardiac receptor control of circulation in man. (1989) (6)
Assessment of sympathetic cardiovascular influences in man: Haemodynamic and humoral markers versus microneurography (1991) (6)
Targets for Body Fat, Blood Pressure, Lipids, and Glucose-Lowering Interventions in Healthy Older People (2013) (6)
Evaluation of a new non-invasive semiautomatic blood pressure monitoring device. (1987) (6)
Ambulatory blood pressure monitoring. (1999) (6)
Value of echocardiographic and ambulatory blood pressure monitoring in hypertension. (1989) (6)
Adherence to treatment by initial antihypertensive mono and combination therapies. (2021) (6)
Myocardial strain and left ventricular geometry: a meta-analysis of echocardiographic studies in systemic hypertension (2021) (6)
Secondary prevention of stroke: Old and new evidence (2002) (6)
SYMPATHETIC, BAROREFLEX AND METABOLIC ABNORMALITIES IN THE OPTIMAL, NORMAL AND HIGH-NORMAL BLOOD PRESSURE STATE: 9C.02 (2010) (6)
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. (2020) (6)
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity. (2011) (6)
Lowering of Blood Pressure—The Lower, the Better? Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884–893, 2006 (2006) (6)
Neural Mechanism in Human Cardiovascular Regulation (1986) (6)
Background and Treatment of Metabolic Syndrome: A Therapeutic Challenge (2006) (6)
Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease. (2020) (6)
Effects of prostaglandin E1alpha cyclodextrin [corrected] treatment on endothelial dysfunction in patients with systemic sclerosis. (2007) (6)
Indexing cardiac parameters in echocardiographic practice: do estimates depend on how weight and height have been assessed? A study on left atrial dilatation. (2011) (6)
Interventional Therapies for Secondary and Essential Hypertension (2016) (6)
Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient. (2019) (6)
CARDIOVASCULAR REGULATION AND ANALYSIS OF BLOOD PRESSURE‐HEART RATE VARIABDLITY INTERACTIONS (1998) (6)
Perindopril 3.5 mg/amlodipine 2.5 mg versus renin–angiotensin system inhibitor monotherapy as first-line treatment in hypertension: a combined analysis (2018) (6)
1991 Guidelines for the prevention of hypertension and associated cardiovascular disease (1992) (6)
Cardiovascular and renal disease in untreated and treated hypertension. (1994) (5)
Clinical and hemodynamic effects of celiprolol in essential hypertension. (1989) (5)
[Hemodynamics and pressure variability in isolated systolic hypertension]. (1994) (5)
Methodological Aspects of Meta-Analyses Assessing the Effect of Blood Pressure–Lowering Treatment on Clinical Outcomes (2021) (5)
Home and ambulatory blood pressure in resistant hypertension. (2013) (5)
The prognostic importance of right ventricular remodeling and the circadian blood pressure pattern on the long-term cardiovascular outcome. (2020) (5)
Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303 (2015) (5)
Carotid baroreceptor reflex in normotensive and hypertensive subjects. (1976) (5)
Clinical value of blood pressure measurements: focus on ambulatory blood pressures. (1992) (5)
Assessing antihypertensive treatment by real life data. (2012) (5)
Prevention of coronary heart disease: the recommendations of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. (1995) (5)
Clinical Management of Coronary Heart Disease in Hypertension (2013) (5)
G64Evaluation of blood pressure changes in post coronary artery bypass patients undergoing physical training (1995) (5)
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study (2012) (5)
Nocturnal blood pressure: the dark side of white-coat hypertension. (2020) (5)
Combination Treatment in Antihypertensive Drug Trials (1997) (5)
Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy (2015) (5)
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes (2016) (5)
P-229: Association of BP control and frequency of mortality and CV morbidity in hypertensive patients with CAD: the international verapamil SR-trandolapril study (2004) (5)
24-hour blood pressure measurements: methodological and clinical problems. (1986) (5)
Angiotensin receptor antagonists and increased risk of cancer. Further evidence against. (2011) (5)
Effects of cigarette smoking on systemic hemodynamics. (2000) (5)
ADVANTAGES AND DISADVANTAGES OF THE META-ANALYSIS APPROACH. DISCUSSION (1996) (5)
Principal results from the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT) (2001) (5)
P-59: Tolerability and safety of telmisartan as monotherapy or combined with hydrochlorothiazide compared with placebo (2002) (5)
[Possible interaction of environment and genetic factors in work-related diseases: the case of hypertension]. (2005) (5)
Disorders of Blood Pressure Regulation (2018) (5)
P-425: Efficacy of self treatment of hypertension at home with device-guided breathing (2002) (5)
Pathophysiology of Hypertension (1997) (5)
Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)‐deficient adult patients and is not improved after short‐term GH replacement therapy (2012) (5)
[Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension]. (2012) (5)
Hypertension and the Heart (2006) (5)
Haemodynamic effects of a new multifactorial antihypertensive drug. (1992) (5)
Ambulatory blood pressure, blood pressure variability and antihypertensive treatment. (1996) (5)
Experience with continuous non-invasive finger blood pressure monitoring: A new research tool. (1995) (5)
Angiotensin II Receptor Antagonists In Perspective (2000) (5)
Vascular effects of lacidipine: a review of animal and human data (1993) (5)
RAAS Inhibitors and Risk of Covid-19. Reply. (2020) (5)
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial (2021) (5)
‘Keep an eye’ on the heart: retinal microcirculation disarray in congestive heart failure (2018) (5)
ESH Hypertension Excellence Centres: a new strategy to combat an old foe. (2007) (5)
New blood pressure control goals, more rational but facilitating therapeutic inertia? : reply. (2013) (5)
The effect of nifedipine GITS on outcomes in patients with previous myocardial infarction: a subgroup analysis of the INSIGHT study (2002) (5)
REDUCED BLOOD PRESSURE LOWERING EFFECT OF CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: DATA FROM POOLED SYMPLICITY HTN TRIALS (2015) (5)
The impact on office blood pressure categories and ambulatory blood pressure discrepancies of the European Society of Hypertension and American Academy of Pediatrics Guidelines for Management of Hypertension in Children and Adolescents. (2019) (5)
Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials (2020) (5)
Patterns of cardiovascular variability after long-term sino-aortic denervation in unanesthetized adult rats (2019) (5)
Termination of the ESH-CHL-SHOT trial. (2020) (5)
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? (2016) (5)
Introduction to a Compendium on the Pathophysiology and Treatment of Hypertension. (2019) (5)
Evaluation of the antihypertensive effect of once-a-day captopril by 24-hour ambulatory blood pressure monitoring (1987) (5)
Implementation of new evidence into hypertension guidelines: the case of the ONTARGET and TRANSCEND trials (2009) (5)
Neuroadrenergic activation in obstructive sleep apnoea syndrome: a new selected meta-analysis - revisited (2022) (4)
24h ambulatory blood pressure variability and carotid artery damage: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) (2000) (4)
Pharmacological Control of Calcium and Potassium Homeostasis (1995) (4)
The role of heart rate in the phenylephrine-induced suppression of premature ventricular beats (1979) (4)
Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies. (2020) (4)
Benefit versus risk of calcium antagonists in hypertensive patients with concomitant risk factors (1996) (4)
Left ventricular hypertrophy in isolated and dual masked hypertension (2020) (4)
Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
3D.01: VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF STROKE OR CARDIAC EVENTS IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL (2015) (4)
Blood Pressure Monitoring (2008) (4)
Failure of monolateral renal nerve ablation to exert sympathoinhibitory and blood pressure lowering effects in a patient with resistant hypertension: a case report. (2013) (4)
Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts (2018) (4)
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. (2008) (4)
Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension. (2016) (4)
Impaired midwall mechanics and biventricular hypertrophy in essential hypertension (2010) (4)
Variant on chromosome 9p is associated with left ventricular mass: results from two cohorts of essential hypertensive individuals (2012) (4)
Short- and Long-Term Reproducibility of Nighttime Blood Pressure Phenotypes and Nocturnal Blood Pressure Reduction (2021) (4)
Highlights of the January issue. (2020) (4)
Chapter 49 – European, American, and British Guidelines: Similarities and Differences (2007) (4)
Blood Pressure and Glucose Control in Patients With Diabetes (2007) (4)
Blood pressure. The forgotten factor in previous and recent studies regarding anticoagulation in atrial fibrillation. (2013) (4)
The U-shaped association between achieved blood pressure and risk of cardiovascular events and mortality in elderly and younger patients. (2020) (4)
History of lower-limb complications and risk of cancer death in people with type 2 diabetes (2021) (4)
Quarter Dose Combination Therapy: Good News for Blood Pressure Control. (2017) (4)
The New American Guidelines on Hypertension: A Favorable Opinion (2014) (4)
Target blood pressure and kidney protection. (2018) (4)
Evaluation of the Antihypertensive Effect of TTS Clonidine by Multiple 24‐Hour Automatic Blood Pressure Monitoring (1986) (4)
[The role of the sympathetic nervous system in essential arterial hypertension and organ damage]. (1995) (4)
Antihypertensive effects of combined lisinopril and hydrochlorothiazide in elderly patients with systodiastolic or systolic hypertension: results of a multicenter trial. (1997) (4)
Pathophysiological aspects of hypertensive disease in women. (2002) (4)
The new International Society of Hypertension guidelines on hypertension. (2020) (4)
Blood pressure control and antihypertensive treatment. (2012) (4)
Cardiovascular regulation and analysis of blood pressure‐heart rate variability interactions (1999) (4)
IRBESARTAN RESULTS IN SUPERIOR BLOOD PRESSURE REDUCTION VS VALSARTAN: P3.223 (2000) (4)
Round Table: What blood pressure to measure? (1991) (4)
Blood pressure control in the hypertensive population. Is the trend favourable? (2013) (4)
Arterial disorders: Definition, clinical manifestations, mechanisms and therapeutic approaches (2015) (4)
Neural Control of Circulation Before and After Intravenous Urapidil in Essential Hypertension (2012) (4)
Spontaneous variability of regional haemodynamics in unanaesthetized rats (1993) (4)
Clinical Value of Ambulatory Blood Pressure Monitoring (1993) (4)
HYPERTENSION IN AORTIC STENOSIS (2019) (4)
Correction to graph in September-October supplement. (1984) (4)
European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces. (2008) (4)
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis (2021) (4)
Research strategies in treatment of hypertension: value of retrospective real-life data. (2022) (4)
[Practice guidelines 2007 for the treatment of arterial hypertension]. (2007) (4)
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk (2021) (4)
Diagnostic algorithm for HFpEF: how much is the recent consensus applicable in clinical practice? (2020) (4)
[Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension]. (1997) (4)
Angiotensin II-Linked Hypothesis to Understand the Advantage of the Coevolution of Hypertension and Malaria: "Sympathy for the Devil". (2016) (4)
Neural influence on canine renal prostaglandin secretion. (1974) (4)
ESH statement on detection and punishment of abstract fraud and poster plagiarism (2005) (4)
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. (2022) (4)
Blood Pressure Variability and Organ Damage in a General Population (2002) (4)
Effect of atrial natriuretic factor on arterial baroreceptor control of heart rate and blood pressure in conscious rats (1988) (4)
2007 ESH–ESC practice guidelines for the management of (2008) (4)
The value of multimodality imaging in hypertensive heart disease. (2020) (4)
Web-Based Telemonitoring of Home Blood Pressure in General Practice (2005) (4)
Time-weighted vs conventional quantification of 24 H average systolic and diastolic ambulatory blood pressures (2004) (4)
Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease? (2016) (4)
Alterations in plasma noradrenaline in response to reflex modulation of sympathetic vasoconstrictor tone to skeletal muscles. (1984) (4)
Targeting blood pressure in the management of total cardiovascular risk (2009) (4)
Angiotensin receptor blockers and myocardial infarction: the importance of dosage (2006) (4)
4A.01: LONG-TERM EFFECTS OF RENAL ARTERY DENERVATION IN REAL WORLD PATIENTS WITH UNCONTROLLED HYPERTENSION FROM THE GLOBAL SYMPLICITY REGISTRY (2015) (4)
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range. (2022) (4)
Arterial compliance in familial hypercholesterolaemia: a preliminary report (1993) (4)
The importance of pulse pressure on cardiovascular risk and total mortality in the general population: Is sex relevant? (2018) (4)
Persistence of arterial functional abnormalities after successful coronary revascularization (2011) (4)
8A.04: RISK OF MORTALITY IN RELATION TO AN UPDATED CLASSIFICATION OF LEFT VENTRICULAR GEOMETRIC ABNORMALITIES IN A GENERAL POPULATION THE PAMELA STUDY (2015) (4)
Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study. (2019) (4)
Reproducibility of blood pressure phenotypes identified by office and ambulatory blood pressure in treated hypertensive patients. Data from the PHYLLIS study (2022) (3)
Current Developments in Stroke (2017) (3)
Evaluation, risk stratification and management of hypertensive patients in the perioperative period. (2019) (3)
The Function of the Autonomic Nervous System in Hypertension (2002) (3)
[Hypertension, left ventricular hypertrophy and heart failure]. (1993) (3)
Alterations of cardiovascular reflexes in hypertension. (1980) (3)
Long-term changes in left ventricular mass echocardiographic findings from a general population (2017) (3)
Assessment of Preclinical Organ Damage in Hypertension (2015) (3)
Treatment of hypertension: General aspects (1996) (3)
Blood pressure, ageing and mortality. (1997) (3)
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage (2022) (3)
Role of Tissue Doppler Imaging for Detection of Diastolic Dysfunction in the Elderly (2011) (3)
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. (2010) (3)
White coat hypertension: An unresolved diagnostic and therapeutic problem (2014) (3)
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes. (2021) (3)
Initial combination treatment in the 2018 ESC/ESH hypertension guidelines. (2019) (3)
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension (2021) (3)
[Arterial hypertension and heart diseases. Diagnostic-therapeutic guidelines. Joint Commission of the National Association of Hospital Cardiologists, the Italian Society of Cardiology and the Italian Society of Arterial Hypertension]. (1999) (3)
Ambulatory blood pressure monitoring by a novel cuffless device: a pilot study (2020) (3)
Left ventricular global longitudinal strain in secondary hypertension: A meta-analysis of echocardiographic studies. (2021) (3)
CHANGES IN ALBUMINURIA PREDICT MORTALITY AND MORBIDITY IN PATIENTS WITH VASCULAR DISEASE: PS.3.04 (2010) (3)
[Significance of ambulatory pressure monitoring in the assessment of antihypertensive agents]. (1999) (3)
Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases (2008) (3)
Left ventricular hypertrophy and hypertension. (1996) (3)
Blood pressure and heart rate variability in conscious rats before and after autonomic blockade: evaluation by wide-band spectral analysis (1993) (3)
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease (2022) (3)
[PP.12.09] MASKED-UNCONTROLLED HYPERTENSION MANAGEMENT BASED ON OFFICE BP OR ON OUT-OF-OFFICE (AMBULATORY) BP MEASUREMENT (MASTER): STUDY PROTOCOL (2017) (3)
A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension. (2020) (3)
Continuous Intra-Arterial Blood Pressure Recording in Human Hypertension (1984) (3)
Definition and Classification of Hypertension (2005) (3)
Computer analysis of blood pressure and heart rate variability in subjects with normal and abnormal autonomic cardiovascular control (2013) (3)
Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk (2021) (3)
Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds (2022) (3)
Acute coronary syndrome: a rare case of multiple endocrine neoplasia syndromes with pheochromocytoma and medullary thyroid carcinoma (2015) (3)
Early twenty-four-hour blood pressure elevation in subjects with parental hypertension. (1989) (3)
Comparing methods for assessing cardiovascular risk. (2009) (3)
Opposite responses of muscle circulation to different emotional stimuli (1971) (3)
BP reduction with the sodium glucose co-transporter 2 inhibitor (SGLT-2i) empagliflozin (EMPA) in type 2 diabetes (T2D) is similar in treatment naïve as in those on one or ≥2 antihypertensive agents – further insights from a dedicated 24h ABPM study (2015) (3)
Effects at 24-h modulation of baroreflex sensitivity on blood pressure variability (1993) (3)
Manual of hypertension (2002) (3)
Ambulatory blood pressure monitoring (1996) (3)
Effects of dilevalol on forearm circulation in essential hypertension. (1989) (3)
1.2 Comparison Between CRP and Other Conventional Risk Factors on Arterial Stiffness in Treated Essential Hypertension (2013) (3)
Abstract 16474: BP Reduction With the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin in Type 2 Diabetes is Similar in Treatment Naïve as in Those on One or ≥ 2 Antihypertensive Agents - Further Insights From a Dedicated 24h ABPM Study (2014) (3)
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials (2017) (3)
[Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension]. (2012) (3)
Carotid intima‐media thickness and anti‐hypertensive treatment: Focus on angiotensin II receptor blockers (2018) (3)
Monday, 27 August 2012 (2012) (3)
Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword. (2019) (3)
CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: A MODEL-BASED ESTIMATE BASED ON 36-MONTH DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2021) (3)
Expertise: No Longer a Sine Qua Non for Guideline Authors? (2017) (3)
[A synthesis of the guidelines of the ESC/EAS/ESH on the prevention of coronary disease and of the guidelines of the Task Force for the Prevention of Coronary Heart Disease. European Society of Cardiology]. (2000) (3)
Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine (1993) (3)
Acute modulation of arterial compliance in mild essential hypertension. (1991) (3)
Ethnic Diversities, Hypertension and Global Cardiovascular Risk (2018) (3)
Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study (2022) (3)
OMAPATRILAT IN PERSONS WITH ENHANCED RISK OF ATHEROSCLEROTIC EVENTS: THE OPERA TRIAL (2000) (3)
The ‘ForLife’ Study (2003) (3)
Hypovolaemia-induced metabolic dysfunction, mediated in part by aldosterone and angiotensin. (2009) (3)
The Sympathetic Nervous System in Hypertension (2018) (3)
Low-dose italy clonidine administration in the treatment of mild or moderate essential hypertension: Results from a double-blind placebo-controlled study (clobass) (1990) (3)
24 H Ambulatory Blood Pressure Variability and Carotid Artery Damage: Baseline Data from the Elsa Study. (2000) (3)
Omega-3 Fatty Acids and Coronary Artery Disease: More Questions Than Answers (2021) (3)
BALANCING CARDIOVASCULAR BENEFIT AND DIABETOGENIC HARM OF THERAPY WITH STATINS: REAL-WORLD EVIDENCE FROM ITALY. (2020) (3)
Ultrasonographic backscatter of the carotid artery wall in patients with HIV infection: A pilot study (2010) (3)
What changes we may expect in 2010 hypertension diagnosis and management: Insights from the European update document. (2010) (3)
8C.04: POSSIBLE ROLE OF ARTERIAL FUNCTION IN CANCER TREATMENT TARGETING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ONCOLOGIC RESPONSE (2015) (3)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. (2022) (3)
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management (1995) (3)
RELATIONSHIP BETWEEN 24-HOUR AMBULATORY BLOOD PRESSURE AND RETINAL VASCULAR ABNORMALITIES IN HYPERTENSION: 3D.03 (2010) (3)
The blood pressure lowering effects of renal denervation in a real world population of patients with uncontrolled hypertension: early outcomes from the Global SYMPLICITY registry (2013) (3)
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state (2018) (3)
[The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology. Società Europea di Cardiologia, Società Europea dell'Aterosclerosi, Società Europea dell'Ipertensione]. (2000) (3)
Metabolic Syndrome in the PAMELA Population: Prevalence, Prognostic Value, Out-Of-Office Blood Pressures and Cardiac Damage (2005) (3)
Balanced 24-hour blood pressure control by angiotensin-converting enzyme inhibitors administered once daily. (1989) (3)
Renal and Cardiovascular Responses to Water Immersion in Essential Hypertension: Is There a Role for the Opioidergic System? (2003) (3)
Effect of Long-Term Antihypertensive Treatment on WhiteCoat Hypertension (3)
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension (2011) (3)
Protocol for an Observational Blood Pressure Study (2004) (3)
Age-related alterations in cardiac parasympathetic responsiveness: a preliminary report. (1989) (3)
Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study. (2019) (3)
Ambulatory central blood pressure: a new opportunity for mechanistic and clinical cardiovascular research. (2013) (3)
Prevention of cardiovascular disease guided by total risk estimations - challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. (2012) (3)
Commentary on Fanaroff et al., Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA. 2019;321(11):1069-80 (2019) (3)
HYPERTENSION AND OBSTRUCTIVE SLEEP APNEA: IS THE BERLIN QUESTIONNAIRE A VALID SCREENING TOOL?: PP.32.273 (2010) (3)
Dihydropiridinic Calcium-Channel Antagonists in the 2007 ESH/ESC Hypertension Guidelines (2008) (2)
Breakthrough in Chronic Hepatitis C During Recombinant Alpha Interferon Therapy (1994) (2)
Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
SAFETY AND EFFICACY OF LOW BLOOD PRESSURE AMONG PATIENTS WITH DIABETES: SUB-GROUP ANALYSES FROM THE ONTARGET TRIAL: 7E.02 (2011) (2)
American Versus European Hypertension Guidelines: The Case of White Coat Hypertension (2020) (2)
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors. (2003) (2)
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension. (1987) (2)
Renal nerve ablation as a tool for studying the interactions between arterial stiffness, blood pressure and sympathetic drive: weight of the evidence. (2013) (2)
190 : the Pamela Study Ambulatory and home blood pressure reference values: the Pamela Study (1993) (2)
A symposium: systemic hypertension: contribution of trandolapril, a new angiotensin-converting enzyme inhibitor, toward patient protection. Introduction. (1992) (2)
Treatment of Hypertension and Prevention of Cardiovascular Morbidity and Mortality (1991) (2)
Renal nerve ablation. (2018) (2)
1.2 Ambulatory Blood Pressure, Target Organ Damage and Aortic Root Size in Never Treated Essential Hypertensives (2007) (2)
Results of Experimental Studies Favoring the Hypothesis of the Influence of Stress on the Genesis of Hypertension (1984) (2)
Improving cardiovascular risk stratification in essential hypertensives by indexing left ventricular mass to height2.7 (2009) (2)
Abstract 092: Global SYMPLICITY Registry: 3 Year Safety and Efficacy Data (2017) (2)
BLOOD PRESSURE TARGETS RECOMMENDED BY GUIDELINES AND INCIDENCE OF CARDIOVASCULAR AND RENAL EVENTS IN THE ONTARGET TRIAL: 9A.08 (2011) (2)
A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension. (2020) (2)
Hypertension: Blood pressure targets for elderly patients: new SPRINT data (2016) (2)
Sympathetic nerve traffic and baroreflex control of circulation in obese patients: a preliminary report (1993) (2)
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis (2020) (2)
Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protection. (2009) (2)
HCV Genotypes and Breakthrough in Patients Treated With Recombinant Alpha Interferon (1998) (2)
QUALITY OF SLEEP IS NOT RELATED TO THE DEGREE OF NOCTURNAL BLOOD PRESSURE FALL: P1.278 (2004) (2)
Hypertension--when is the clinical problem solved? When patients are rendered normotensive. (1994) (2)
Treating very elderly hypertensive patients is rewarding: The HYVET results (2008) (2)
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 Guido (2009) (2)
[Dynamic assessment of the sensitivity of heart baroreflexes control: new perspectives]. (1999) (2)
THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women (2021) (2)
Reporting blood pressure effects of antihypertensive treatment in scientific papers: are guidelines needed? (2012) (2)
Blood pressure reduction as part of the multifactorial approach to treatment of cardiovascular disease (2001) (2)
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. (2022) (2)
Treating hypertension in the elderly. (1993) (2)
Predictive value of different indices of blood pressure variability on (2014) (2)
Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper (2023) (2)
Perioperative SBP changes during orthopedic surgery in the elderly: clinical implications. (2019) (2)
The metabolic syndrome - a therapeutic challenge (2007) (2)
Effects on blood pressure variability of vagal versus sympathetic modulation of the heart in rats (1986) (2)
Problems involved in automatic blood pressure monitoring. (1985) (2)
Old and new approaches for evaluating autonomic control of circulation in man. (1996) (2)
DOES HEART RATE REFLECT ACUTE CHANGES IN SYMPATHETIC CARDIOVASCULAR DRIVE?: 6B.3 (2000) (2)
Compliance studies in ELSA. European Lacidipine Study of Atherosclerosis. (1996) (2)
BAROREFLEX ACTIVATION THERAPY REDUCES HOSPITAL RESOURCE UTILIZATION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (2014) (2)
Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses (2016) (2)
Calcium antagonists in the treatment of arterial hypertension. (1993) (2)
Mechanisms of impaired parasympathetic control of the heart in hypertension: evidence against reduced cardiac vagal responsiveness. (1991) (2)
Twenty-four-hour blood pressure and antihypertensive treatment. (1992) (2)
3.12 Angiotensin II Receptor Blockers and Risk of Myocardial Infarction: a Meta-Analysis of Randomized Clinical Trials Updated Until May 1, 2008 (2008) (2)
Regional blood flows during desynchronized sleep in the cat (1969) (2)
Incident aortic root dilatation in the general population: findings from the Pamela study (2021) (2)
Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
World Health Organization - International Society of Hypertension Guidelines and the role of ongoing trials (2000) (2)
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. (2016) (2)
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease (2013) (2)
Issues in the development of new combinations of blood pressure lowering drugs (2010) (2)
Guidelines for Home Blood Pressure Monitoring (2019) (2)
Thiazide diuretics : first-line therapy for hypertension. Discussion (1992) (2)
THE IMPACT OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE VARIABILITY ON MORTALITY IS MODIFIED BY AGEING. DATA FROM THE DUBLIN OUTCOME STUDY (2019) (2)
Activation by Cigarette Smoking in Humans (2005) (2)
Response to 'Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension'. (2019) (2)
TCT-84 Renal Denervation With Symplicity Spyral Catheter in the Global Symplicity Registry: Safety and Efficacy at 3 Years (2019) (2)
[Neurohumoral mechanisms in cardiocirculatory decompensation]. (1994) (2)
MORNING BLOOD PRESSURE SURGE AND LEFT VENTRICULAR MASS IN TREATED HYPERTENSIVE PATIENTS: 8C.5 (2004) (2)
Chapter 7 – White Coat and Masked Hypertension (2013) (2)
Clinical Event Reductions in High-Risk Patients After Renal Denervation Projected from the Global SYMPLICITY Registry. (2022) (2)
Sea level training to paced slow breathing prolongs its positive effects on arterial oxygen content and autonomic cardiac modulation under exposure to altitude hypobaric hypoxia (2006) (2)
Update the set of principles and beliefs (2008) (2)
Antihypertensives in octogenarians (2012) (2)
[OP.1A.08] COMPARISON BETWEEN OFFICE AND AMBULATORY BLOOD PRESSURE IN ASSESSING THE REDUCTION OF BLOOD PRESSURE: A META-ANALYSIS (2016) (2)
Attended vs. unattended blood pressure – learnings beyond SPRINT (2021) (2)
Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry (2013) (2)
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. (2020) (2)
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project (2022) (2)
Neural Factors in Essential Hypertension (1984) (2)
BLOOD PRESSURE CONTROL IN EUROPE (2008) (2)
Short‐and long‐term reproducibility of techniques employed to assess sympathetic tone in humans: a preliminary report (1993) (2)
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified (2022) (2)
A new measure of baroreflex effectiveness in modulating heart rate in daily life (1999) (2)
On the state of the Journal (2006) (2)
The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil (2000) (2)
Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk (2022) (2)
Structural arteriolar changes in diabetes mellitus. (1997) (2)
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure (2022) (2)
Decreased ascites occurrence in interferon (IFN) treated HCV cirrhosis: results of a survey of a large cohort of interferon treated and untreated patients (2002) (2)
Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study (2022) (2)
8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY (2015) (2)
AMBULATORY BLOOD PRESSURE MONITORING BY A NOVEL CUFFLESS DEVICE IN CLINICAL PRACTICE (2019) (2)
[The ALLHAT study: contributions, limitations and prospectives]. (2003) (2)
HYPERTENSION PHENOTYPES DEFINED BY OFFICE AND AMBULATORY BLOOD PRESSURE IN 9,153 SUBJECTS REFERRED TO HYPERTENSION CLINICS IN FOUR CONTINENTS: THE ARTEMIS INTERNATIONAL REGISTRY: LB3.6 (2011) (2)
Arterial compliance in obese young subjects: a preliminary report (1993) (2)
Neural mechanisms in hypertension and the elderly. (1995) (2)
Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine. (2019) (1)
EFFECTS OF ACUTE CHANGES IN BLOOD VISCOSITY ON RADIAL ARTERY FLOW MEDIATED DILATATION IN HEMOCHROMATOSIS PATIENTS: P3.123 (2000) (1)
TWO-DRUG FIXED-DOSE COMBINATION AS INITIAL ANTIHYPERTENSIVE TREATMENT STRATEGY CONFERS HIGHER MEDICATION ADHERENCE COMPARED TO MONOTHERAPY (2021) (1)
[BP.01.02] URIC ACID AND NEW ONSET LEFT VENTRICULAR HYPERTROPHY: FINDINGS FROM THE PAMELA POPULATION. (2017) (1)
STATIN TREATMENT REDUCES THE RISK OF DEATH AMONG ELDERLY FRAIL PATIENTS. EVIDENCE FROM A LARGE POPULATION-BASED COHORT (2021) (1)
Reply to blood pressure target in chronic kidney disease. (2013) (1)
Journal of Hypertension: Introduction (2006) (1)
Current Developments in Stroke: vol 1 New Concepts in Stroke Diagnosis and Therapy (2017) (1)
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension. (2022) (1)
The threat of diabetes to public health. Introduction. (2009) (1)
5.6 The HYPERPRACT Study: a Multicentre Survey on the Accuracy of the Echocardiographic Assessment of Hypertensive Left Ventricular Hypertrophy In Clinical Practice (2008) (1)
156 Reduced baroreflex sensitivity with ageing: dynamic evaluation of computer analysis of twenty-four-hour continuous blood pressure recordings in humans (1993) (1)
Continuous Blood Pressure Monitoring in the Clinical Evaluation of Hypertensive Patients and in the Study of Neural Cardiovascula Control (1984) (1)
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease (2020) (1)
Hypertension: Quarter dose quadpill combinations: a new therapeutic approach (2017) (1)
Mancia and Grassi Autonomic Nervous System and Hypertension (2014) (1)
Knocking on heaven's door: The gap between health institutions and academies in generating knowledge utilizing real-world data (2022) (1)
[The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]. (1992) (1)
EFFECTS OF TREATMENT WITH ACE-INHIBITOR AT HIGH DOSE OR ANGIOTENSIN II RECEPTOR ANTAGONIST ON ARTERIAL DISTENSIBILITY IN HEART FAILURE: 3B.6 (2000) (1)
Early sympathetic activation in mild renal failure (2006) (1)
The Hypertension Guidelines of the Seventh Joint National Committee (2004) (1)
New threshold and target blood pressures in the hypertension guidelines. Which implications for the hypertensive population? (2015) (1)
Early alterations in left ventricular diastolic function in normotensive diabetic patients (2012) (1)
Selected Abstracts From XXXIV National Congress of the Italian Society of Hypertension (SIIA), Milan, 5–7 October 2017 (2017) (1)
Hypertensive urgencies and emergencies: reducing the gap between guidelines and clinical practice. (2014) (1)
Blood Pressure Measurement, White-Coat and Masked Hypertension (2018) (1)
Calcium channel blockade: is lowering office blood pressure enough? (1995) (1)
A NEW METHOD FOR ASSESSING 24 H BLOOD PRESSURE VARIABILITY CORRECTING FOR THE CONTRIBUTION OF NOCTURNAL BLOOD PRESSURE FALL: OP 148 (2004) (1)
Blood Pressure Variability , Carotid Atherosclerosis and Cardiovascular Events in the European Lacidipine Study on Atherosclerosis Running title : Mancia et al . ; Long-term BP variability and organ damage (2012) (1)
Chapter 13 Hypertension (2009) (1)
BENEFIT OF INDAPAMIDE-BASED TREATMENT ON MORTALITY (2019) (1)
REFERENCE VALUES FOR CLINICAL USE OF THE SMOOTHNESS INDEX (2004) (1)
Methodological aspects: general discussion (1996) (1)
SUBGROUP ANALYSIS OF LONG-TERM BLOOD PRESSURE REDUCTION IN THE GLOBAL SYMPLICITY REGISTRY (2019) (1)
Biological and social values of metabolic syndrome in predicting cardiovascular disease (2009) (1)
Ambulatory Blood Pressure Monitoring (ABPM) in the VALUE Trial (2005) (1)
European Society of Hypertension: a note from the President (2000) (1)
Haemodynamic Effects of the Multiple Action Antihypertensive Drug Urapidil (2012) (1)
Response to 'Valid measure of central arterial pressure and arterial stiffness?' (2007) (1)
LEFT VENTRICULAR GEOMETRY, AMBULATORY BLOOD PRESSURE AND EXTRACARDIAC ORGAN DAMAGE IN UNTREATED ESSENTIAL HYPERTENSION: PP.22.380 (2010) (1)
Effect of Oral Dilevalol on Forearm Circulation in Essential Hypertension (1992) (1)
Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST) (2004) (1)
[The role of angiotensin II inhibitors in arterial hypertension: clinical trials and guidelines]. (2000) (1)
The PAMELA research project: a 25-year long journey (2021) (1)
ACUTE REDUCTION OF AORTIC STIFFNESS IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION AS A MARKER OF EFFICACY OF RENAL DENERVATION THERAPY (2015) (1)
Response to Possible Difference in the Sympathetic Activation on Extreme Dippers With or Without Exaggerated Morning Surge (2009) (1)
Aortic Distensibility by Nuclear Magnetic Resonance in Esential Hypertension (2007) (1)
INFUSION OF E. COLI LIPOPOLYSACCHARIDES TOXIN IN RATS PRODUCES A SEVERE IMPAIRMENT OF BAROREFLEX FUNCTION IN ABSENCE OF BLOOD PRESSURE CHANGES: PP.32.261 (2010) (1)
2.3 New-Onset Diabetes Mellitus and Impaired Fasting Glucose in White Coat, Masked And Sustained Hypertension: the PAMELA Study (2008) (1)
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. (2019) (1)
P-328: Hypertension assessment and management in general medicine. The SPHYGMO project (2001) (1)
Ambulatory blood pressure monitoring in treated patients with hypertension in the COVID-19 pandemic - The study of European society of hypertension (ESH ABPM COVID-19 study). (2023) (1)
Compliance studies in ELSA (1996) (1)
Acetazolamide Counteracts Ambulatory Blood Pressure Increase Under Acute Exposure to High Altitude: 3a.05 (2011) (1)
Psychophysiology of Heart Disease (2006) (1)
[Electric stimulation of muscle afferents of group I in the acute decorticated cat]. (1966) (1)
TIMP1 plasma levels are correlated with arterial stiffening process (2011) (1)
Hypertension: Does antihypertensive treatment have long-term benefits? (2012) (1)
Position Paper: The Control of Renin Release (1981) (1)
Mechanisms Responsible for the Age-Related Sympathetic Activation (2005) (1)
9.9 Role of the Different Components of Metabolic Syndrome in the Pathogenesis of Adrenergic Overdrive (2008) (1)
Erratum: Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients by Mario T Kratz et al. (European Journal of Preventive Cardiology (2014) 21 (272-280) DOI: 10.1177/2047487313494835) (2015) (1)
Executive Summary of the Joint Position Paper on Renal Denervation of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the European Society of Hypertension (ESH) (2016) (1)
[The control of blood pressure in a hypertensive population]. (1997) (1)
Mitral deceleration index is associated with aortic root dilatation and not to biventricular structural changes in essential hypertension (2011) (1)
RELATIONSHIPS BETWEEN SERUM URIC ACID AND BLOOD PRESSURE, METABOLIC VARIABLES AND CARDIOVASCULAR RISK PROFILE IN TREATED HYPERTENSIVE PATIENTS FROM CENTRAL AND EASTERN EUROPEAN COUNTRIES: RESULTS OF THE BP-CARE STUDY (2018) (1)
Ambulatory blood pressure monitoring in the diagnosis of hypertension and evaluation of antihypertensive drug efficacy. (1994) (1)
Pharmacological improvement of large arteries properties. (1999) (1)
2B.01: IRON OVERLOAD EXERTS SYMPATHOEXCITATORY EFFECTS IN MEN WITH ESSENTIAL HYPERTENSION MICRONEUROGRAPHIC EVIDENCE (2015) (1)
3C.01: ADVERSE PROGNOSTIC VALUE OF PERSISTENT OFFICE BLOOD PRESSURE ELEVATION IN WHITE COAT HYPERTENSION (2015) (1)
Home Blood Pressure Monitoring (2003) (1)
Abstract 15570: Acute Baroreceptor Activation Therapy Improves Hemodynamics in Heart Failure with Reduced Ejection Fraction: Early Results from a Chronic Pilot Investigation (2012) (1)
Applying evidence-based medicine to current practice: a round table panel discussion (2000) (1)
PRE-HYPERTENSION AND SUBCLINICAL CARDIAC DAMAGE: A META-ANALYSIS OF ECHOCARDIOGRAPHIC STUDIES (2018) (1)
Abstract 204: Blood Pressure Reduction And Stroke Recurrence: The Progress Trial (2013) (1)
Risk of Cardiovascular and All Cause Mortality in Patients with ???White Coat??? or ???Masked??? Hypertension: Results from the PAMELA Study (2005) (1)
Cardiometabolic risk in high-normal blood pressure state: mechanistic insights. (2009) (1)
Haemodynamic effects of antihypertensive agents in man (1984) (1)
Hemodynamic patterns during fighting behaviour in the cat (1968) (1)
Alberto Zanchetti (27 July 1926). (2018) (1)
50 – Updated American Heart Association/American College of Cardiology; European Society of Hypertension/International Society of Hypertension Guidelines (2018) (1)
Interplay of sino-aortic reflexes and haemodynamic changes during natural sleep in the cat. (1976) (1)
[The difference between clinical ambulatory measured blood pressure and daily monitored pressure does not reflect the "white coat effect"]. (1997) (1)
LIMITED REPRODUCIBILITY OF MUCH AND WUCH (2019) (1)
Highlights of the August issue. (2018) (1)
4C.07: RELATIONSHIPS BETWEEN COGNITIVE DYSFUNCTION, CLINIC AND AMBULATORY BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY RESULTS FROM THE PAMELA STUDY (2015) (1)
THE IMPACT OF EXAGGERATED BLOOD PRESSURE RESPONSE DURING TREADMILL EXERCISE TEST ON OUTCOME IN MODERATE TO SEVERE ASYMPTOMATIC AORTIC STENOSIS PATIENTS (2018) (1)
Why we do not need a single independent international hypertension clinical practice guideline. (2021) (1)
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial (2020) (1)
The TALENT Study (2008) (1)
Office and Out-of-Office Blood Pressure Changes Over a Quarter of Century (2020) (1)
Obstructive Sleep Apnea, CPAP and Arterial Hypertension: A Cardiologist's View Point. (2021) (1)
MICROALBUMINURIA IN ESSENTIAL HYPERTENSION AND DIABETES MELLITUS. DISCUSSION (1996) (1)
225 Portal pressure gradient (HVPG) reduction after long-term K-canrenoate in postviral child a cirrhosis with small esophageal varices (F1): Lack of sympathoinhibitory effects (2004) (1)
Therapeutic strategies to lower and control high blood pressure (2009) (1)
Joint Editorial for the International Society of Hypertension Guidelines. (2020) (1)
Non-invasive, continuous, twenty-four-hour blood pressure recording (1991) (1)
Real-world data: how they can help to improve quality of care (2021) (1)
PP.LB01.21: A PROPOSAL FOR THE IDEA OF A FLEXIBLE-COMBINATION POLYPILL IN ARTERIAL HYPERTENSION (2015) (1)
Arterial distensibility in hypercholesterolemia and diabetes. (1999) (1)
[Secondary prevention of stroke through arterial blood pressure reduction]. (1997) (1)
Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE. (2022) (1)
International Consensus on Standardized Clinic Blood Pressure Measurement - A Call to Action. (2023) (1)
Use and Abuse of Clinical Trials (1994) (1)
[PP.01.18] COMPARISON OF A NEW FIRST-LINE TREATMENT VERSUS DIFFERENT FIRST-LINE STRATEGIES USING 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING (2016) (1)
9A.04: CARDIOVASCULAR RISK FACTOR PROFILE IN AN ITALIAN COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS RESULTS OF A THREE YEARS FOLLOW-UP (2015) (1)
Ambulatory blood pressure monitoring and antihypertensive treatment. (1992) (1)
Comparison of videodensitometric analysis and integrated backscatter tissue characterization by ultrasound in carotid arteries (2007) (1)
ANTIHYPERTENSIVE TREATMENT STRATEGIES (2014) (1)
LEFT VENTRICULAR HYPERTROPHY AND ABDOMINAL AORTA SIZE IN ESSENTIAL HYPERTENSION: PP.22.177 (2011) (1)
Prevention and treatment of hypertension study (PATHS): Alcohol reduction for hypertension and upper normal blood pressure (1995) (1)
Secondary Hypertension and Cardiovascular Risk: An Overview (2020) (1)
Angiotensin II Receptor Antagonists : Current Perspectives (2006) (1)
[Significance of continuous monitoring of arterial blood pressure in the diagnosis of hypertension]. (1986) (1)
Sympathetic activation and baroflex dysfunction in the metabolic syndrome (2005) (1)
Effects of Renal Denervation on Sympathetic Nerve Traffic and Correlates in Drug-Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis (2023) (1)
What is the impact of blood-pressure control on cardiovascular events in patients with diabetic nephropathy? (2006) (1)
Sympathetic nervous system: The link between heart failure, hypertension, and NIDDM: Proceedings from a satellite symposium at the XIXth congress of the European Society of Cardiology (ESC), held in Stockholm, Sweden, August 27, 1997. Introduction (1998) (1)
Insights From Matched Office and Ambulatory Blood Pressure in Youth: Clinical Relevance (2022) (1)
Target blood pressure values in the US and European Guidelines. Are they truly similar? (2019) (1)
Invited review Blood pressure control based on office and ambulatory blood pressure monitoring: the European experience in hypertensive patients treated in clinical practice (2009) (1)
Cost-effectiveness of the adherence with recommendations for clinical monitoring of patients with diabetes. (2021) (1)
[Hemodynamic modifications during natural sleep in cats]. (1967) (1)
The pressioni arteriose monitorate e loro associazioni (PAMELA) research project: a 25-year long journey. (2021) (1)
History of Prehypertension: Past and Present, a Saga of Misunderstanding and Neglect (2018) (1)
Two different hemodynamic patterns underlying hypotension during desynchronized sleep (1967) (1)
Masked Uncontrolled Hypertension. (2019) (1)
TCT-762 Renal denervation treatment with the Symplicity Spyral multielectrode catheter: 6-month safety and blood pressure outcomes from the Global SYMPLICITY Registry. (2016) (1)
BLOOD PRESSURE TARGETS OF ANTIHYPERTENSIVE TREATMENT (2014) (1)
Consensus document on the management of patients with obstructive sleep apnea and hypertension. (2010) (1)
A new dawn in cardiovascular protection: blood pressure lowering through AT1 blockade. Introduction. (2003) (1)
[BP.10.01] PROGNOSTIC SIGNIFICANCE OF REVERSE DIPPING PATTERN IN HYPERTENSION: A META-ANALYSIS (2017) (1)
Cardiovascular gene centric association study of metabolic syndrome and ambulatory blood pressure in the PAMELA study (2008) (1)
Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke (2021) (1)
Arterial Alterations in Hypertension (2015) (1)
Have we attained the right control of hypertension? Consequences of the 2013 European Society of Hypertension/European Society of Cardiology and Eighth Joint National Committee recommendations. (2014) (1)
An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors (2013) (1)
Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation. (2019) (1)
RELATION BETWEEN 24H BLOOD PRESSURE VARIABILITY AND LEFT VENTRICULAR MASS IN TREATED HYPERTENSIVE PATIENTS: P3.32 (2004) (1)
Treatment of associated risk factors (2011) (1)
Presidential lecture hypertension and stroke: Opportunities for prevention and prospects for protection (1993) (1)
[Arterial hypertension, sympathetic nervous system, and organ lesion]. (1995) (1)
ANTIHYPERTENSIVE DRUG TREATMENT DOES NOT ALLOW TO ACHIEVE A FULL NORMALIZATION OF THE ARTERIAL STIFFNESS AND METALLOPROTEINASES ALTERATIONS SEEN IN HYPERTENSION: 5C.03 (2011) (1)
Alterations of the cardiopulmonary reflex with hypertension and aging in man. (1989) (1)
Uric acid and xantine-oxidase inhibitors in patients with gout: A re-assessment and an update. (2019) (1)
Calcium antagonists in the treatment of hypertension (1990) (1)
PREDICTIVE VALUE OF ABPM DERIVED VASCULAR INDICES IN DIFFERENT AGE STRATA. RESULTS OF DUBLIN OUTCOME STUDY: 6A.06 (2011) (1)
Effects of systemic hypertension on arterial dynamics and left ventricular compliance in patients >/=70 years of age. (2000) (1)
Automatic cuff inflation during ambulatory blood pressure monitoring does not attenuate night-time hypotension and bradycardia (1994) (1)
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha1-adrenergic receptor antagonist, trimazosin, in hypertension (2005) (1)
4A.04: EFFECTS OF RENAL DENERVATION ON ASYMMETRIC DIMETHYLARGININE AND SYMPATHETIC NERVE TRAFFIC IN RESISTANT HYPERTENSIVE PATIENTS (2015) (1)
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings (2019) (1)
Magnitude and time course of the sympathoinhibitory and blood pressure lowering effects of renal denervation in resistant hypertensive patients (2013) (1)
Cardiopulmonary Receptor Control of Skeletal Muscle Circulation and Renin Release in Normotensive and Hypertensive Subjects (1987) (1)
Prevention of type 2 diabetes mellitus with antihypertensive drugs. (2006) (1)
The new International Society of Hypertension guidelines on hypertension. (2020) (1)
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study (2012) (1)
Cardiovascular changes during spontaneous micturition in conscious cats. (1979) (1)
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality (2022) (1)
P-238: Characteristics predicting blood pressure responses in 22,599 patients with hypertension and coronary artery disease: the International Verapamil SR/Trandolapril study (2002) (1)
Excitation of sham rage behaviour by controlled electrical stimulation of group I muscle afferents (1966) (1)
Clinical trials with ambulatory blood pressure monitoring: Evidence from the Syst-Eurtrial (1995) (1)
[Physiopathologic and clinical features of hypertensive cardiopathy]. (1994) (1)
[Clinical applications of methods for assessing the autonomic nervous system]. (2001) (1)
Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/H (2015) (1)
389524-h systolic blood pressure load represents an important variable in determining the cardiovascular risk of white-coat hypertension (2017) (0)
AMBULATORY BLOOD PRESSURE MONITORING BY A NOVEL CUFFLESS DEVICE: POTENTIAL ROLE IN OVERWEIGHT PATIENTS (2021) (0)
CLASSICAL AND NEW RISK FACTORS (2014) (0)
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project (2011) (0)
Simple cardiovascular risk stratification using anthropometric measures instead of serum cholesterol. The MORGAM Prospective Cohort Project (2020) (0)
adults born very preterm with low diffusion capacity Pulmonary gas exchange efficiency during exercise breathing normoxic and hypoxic gas in (2015) (0)
CHANGE IN COGNITIVE FUNCTIONS DURING ACUTE EXPOSURE TO HYPOBARIC HYPOXIA AT HIGH ALTITUDE: 5B.07 (2011) (0)
[Monitoring of blood pressure for 24 hours: historical, technical, and methodological features]. (1999) (0)
Newly prescribed antihypertensive medications and risk of hip fracture in the elderly (2015) (0)
[Gradual reduction of arterial pressure and 24-hour blood pressure control as objective of antihypertensive therapy]. (1995) (0)
4.5 Prevalence and Clinical Correlates of Multiple Organ Damage in a Never Treated Hypertensive Population (2007) (0)
Emerging Clinical Applications of Ambulatory Blood Pressure Recording (1993) (0)
[PP.32.04] PREDICTORS OF PWV PROGRESSION OVER A THREE YEARS FOLLOW UP: FOCUS ON PSYCHOLOGICAL CHARACTERISTICS (2016) (0)
Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management (2022) (0)
Monographic issue of pharmacological research on hypertension. (2018) (0)
Highlights of the October issue. (2020) (0)
Highlights of the June issue. (2021) (0)
New Aspects of Antihypertensive Treatment (2012) (0)
Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy (1999) (0)
Sleep and the Cardiovascular System (2013) (0)
ARTERIAL STRUCTURE AND FUNCTION IN AIDS PATIENTS: THE IMPACT OF RENAL DAMAGE: PP.35.469 (2010) (0)
S-35-2: THE IMPACT OF RENAL DENERVATION PROCEDURE ON THE USE OF ANTIHYPERTENSIVE DRUGS. A REAL-LIFE INVESTIGATION FROM ITALY (2023) (0)
[OP.5C.07] DO COMBINED ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC MARKERS OF LEFT VENTRICULAR HYPERTROPHY IMPROVE CARDIOVASCULAR RISK ESTIMATION? (2016) (0)
BLOOD PRESSURE REDUCTION AFTER CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE GLOBAL SYMPLICITY REGISTRY (2022) (0)
EARLY BLOOD PRESSURE CONTROL BY THE NIFEDIPINE GITS/TELMISARTAN COMBINATION: HT.1.01 (2010) (0)
D031: Early cardiac structural and functional alterations in IDDM (1998) (0)
[Hemodynamics during sleep in the cat]. (1968) (0)
Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
Consensus Document Central Blood Pressure Measurements and Antihypertensive Therapy: A (2007) (0)
151 Twenty-four hour non-invasive ambulatory blood pressure monitoring by AM5600 versus simultaneous intra-arterial recording in essential hypertensives (1993) (0)
P-35: Response and compliance of hypertensives to treatment by device-guided breathing exercises: Interim results* (2001) (0)
New blood pressure goals: what should they be? How well can this be achieved? (1999) (0)
Clinical implications of PROGRESS: questions and answers (2003) (0)
305 HEART TISSUE CHARACTERIZATION IN HCV CIRRHOSIS: EVIDENCE OF CARDIAC HYPERTROPHY (2008) (0)
New-onset aortic dilatation in the population: a quarter-century follow-up (2022) (0)
Special conditions: diagnosis and treatment (2008) (0)
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes. (2022) (0)
Effects of Valsartan on the Reduction of Left Ventricular Mass and PICP Levels in Hypertensive Patients: 8.12 (2005) (0)
Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea (2021) (0)
Reflex cardiovascular control in health and cardiovascular disease (1990) (0)
Current and future role of catapresan in the treatment of hypertension (1988) (0)
INCIDENT AORTIC ROOT DILATATION IN THE GENERAL POPULATION: FINDINGS FROM THE PAMELA STUDY. (2022) (0)
Subject Index, Vol. 6 (Suppl. 2), 1986 (1986) (0)
EFFECTS OF ACETAZOLAMIDE ON BLOOD PRESSURE AND PULSE WAVEFORM CHANGES INDUCED BY HIGH ALTITUDE EXPOSURE: PP.22.174 (2011) (0)
CARDIOVASCULAR OUTCOMES AT RECOMMENDED BLOOD PRESSURE TARGETS IN MIDDLE AGED AND ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION (2021) (0)
Olmesartan Medoxomil (2010) (0)
Broad band spectral analysis: Pathophysiological and clinical relevance (1999) (0)
SINGLE NUCLEOTIDE POLYMORPHISM INFLUENCE ON ARTERIAL STIFFNESS IN HYPERTENSION: PP.20.131 (2011) (0)
Dissociation between skin (SSNA) and muscle (MSNA) sympathetic nerve activity in liver cirrhosis (2001) (0)
[OP.4C.01] ANTIHYPERTENSIVE DRUG TREATMENT FAILS TO NORMALIZE SYMPATHETIC ACTIVITY: MICRONEUROGRAPHIC EVIDENCE AND CLINICAL IMPLICATIONS (2016) (0)
Heart Rate Circadian Variation Parameters in 24 Hour Ambulatory Blood Pressure Monitoring ??? Their Characteristics and Clinical Relevance: 1.11 (2005) (0)
Abstracts from 2020 national congress of the Italian Society of Hypertension (SIIA) (2020) (0)
8.2 Role of Sympathetic Nervous System in the Excessive Blood Pressure Responses to Physical Exercise (2007) (0)
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study (2011) (0)
Relationship between Structure and Function of Large Arteries and of Left Ventricle in a General Population: ???Pamela Brianza???, Heart-Vessel Substudy (2005) (0)
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes (2018) (0)
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials (2021) (0)
Reply. (2020) (0)
[40] EFFECTS OF THE DURATION OF THE DISEASE AND OF ANTIRETROVIRAL TREATMENT ON CAROTID WALL STRUCTURE IN HIV PATIENTS (2009) (0)
Target organ damage: measurements and clinical importance (2008) (0)
Reflex cardiovascular control in congestive heart failure. Discussion (1992) (0)
Satellite Symposium on Do European Hypertensive Patients Get Optimal Treatment? at XXth Congress of the European Society of Cardiology, Vienna, Austria, 22 August 1998: Introduction (1998) (0)
SYMPATHETIC ACTIVATION IN CONGESTIVE HEART FAILURE AND ITS CORRELATES (2019) (0)
Computeranalysis of cardiovascular signals. (1995) (0)
Proceedings Hyperium Symposium—ASH San Francisco, May 2001: Introduction (2001) (0)
Blood pressure reduction in higher cardiovascular risk patients in the Global SYMPLICITY Registry (2022) (0)
Therapeutic approach in special conditions (2011) (0)
DIFFERENT MEASURES OF 24 H BLOOD PRESSURE VARIABILITY AND ITS NOCTURNAL FALL IN RELATION TO LEFT VENTRICULAR STRUCTURE AND FUNCTION IN HYPERTENSION. EVIDENCE FROM THE SAMPLE STUDY: P1.13 (2004) (0)
[Effects of total sympathectomy on hemodynamic changes in desynchronized sleep]. (1968) (0)
Response to: Myocardial fibrosis and arrhythmogenesis in elite athletes (2019) (0)
Mancia Guido Grassi , Carlo Turri , Gino Seravalle , Giovanni Bertinieri , Alberto Pierini and Giuseppe Function in Heart Failure Effects of Chronic Clonidine Administration on Sympathetic Nerve Traffic and Baroreflex (2001) (0)
Associated risk factors (2008) (0)
4.32 A Non-Invasive Method to Assess Haemodynamic Variations in Patients with Chronic Heart Failure (2007) (0)
I1 imidazoline receptors: Clinical relevance in hypertensive patients (2000) (0)
Highlights of the May issue. (2021) (0)
Highlights of the August issue. (2021) (0)
ADRENERGIC AND REFLEX ABNORMALITIES IN HYPERTENSIVE PATIENTS WITH CONGESTIVE HEART FAILURE: 3C.3 (2000) (0)
Blood Pressure control and cardiovascular protection (2010) (0)
7.2 Relation between Adrenergic Tone, Insulin Resistance and Left Ventricular Hypertrophy in Human Obesity (2007) (0)
Highlights of the July issue. (2020) (0)
24 h glycemia variability correlates with arterial structure alteration in type 1 diabetes (2008) (0)
9.4 Reproducibility Patterns of Plasma Noradrenaline and Muscle Sympathetic Nerve Traffic In Human Obesity (2008) (0)
, Janice and Stroke in Patients With Coronary Artery Disease Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction (2014) (0)
HyperChildNET: A European Network Moving Forward in the Field of Pediatric Hypertension. (2023) (0)
Better adherence to lipid-lowering treatment by a fixed-dose than a free combination of statin and ezetimibe (2020) (0)
Highlights of the August issue. (2019) (0)
EFFECTS OF NIFEDIPINE GITS AND DIURETICS ON PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION – A SUBANALYSIS OF THE INSIGHT STUDY: 7A.3 (2004) (0)
24-Hour Blood Pressure Monitoring Correlates Better Than Office Measurements with Activity Disease in Rheumatoid Arthritis: 1.10 (2005) (0)
TCT-559 Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) (0)
TCTAP A-048 Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) (0)
P1688Behavior of indices of sympathetic activity in relation to sleep time duration in untreated hypertensives (2019) (0)
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome (2011) (0)
Yet another statistic to index baroreflex function (multiple letters) (2001) (0)
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study (2020) (0)
PL 01-1 CARDIOVASCULAR PROTECTION IN HYPERTENSION. WHICH TARGETS FOR TREATMENT. (2016) (0)
B031: Role of pulse pressure in determining structural vascular changes in hypertension (2000) (0)
Arterial stiffness and cardiac damage progression are associated in essential hypertension patients. (2010) (0)
Abstracts from the 13th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 12–14 March 2015 (2015) (0)
DOGMA DISPUTED: J-SHAPED CURVE IN HYPERTENSIVE PATIENTS WITH CAD (2004) (0)
Organ Damage and Blood Pressure in Untreated and Treated Hypertensives (2015) (0)
Nervous System Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction (2008) (0)
SEASONAL INFLUENCES ON AMBULATORY BLOOD PRESSURE. AN INSIGHT FROM THE HARVEST STUDY. AUTHORS' REPLY (1999) (0)
P-542: Sympathetic activation and reflex abnormalities in the metabolic syndrome (2005) (0)
GREATER CONTRIBUTION OF HYPERCHOLESTEROLEMIATHAN OTHER CARDIOVASCULAR RISK FACTORS IN DETERMINING CONDUIT ARTERY ENDOTHELIAL DYSFUNCTION: P 073 (2004) (0)
TIME-WEIGHTED VS CONVENTIONAL QUANTIFICATION OF 24 HOUR AVERAGE AMBULATORY SYSTOLIC BLOOD PRESSURE: 7C.2 (2004) (0)
[OP.4A.01] SYSTOLIC VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF MYOCARDIAL INFARCTION AND CONGESTIVE HEART FAILURE IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL (2016) (0)
Continuous positive air pressure treatment acutely improves pulmonary gas diffusion and reduces pulmonary artery pressure at altitude (2006) (0)
Abstract P356: Comparing Short-term and Long-term Absolute Cardiovascular Risk Prediction Models in a Low-incidence Country: Insights from the CAMUNI Absolute Risk Equation in Northern Italy (2013) (0)
Highlights of the December issue. (2018) (0)
Current problems in clinical hypertension: summary of a workshop held in Martinique, 29-31 October 1989. (1990) (0)
68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2012) (0)
BEHAVIOUR OF REGIONAL SYMPATHETIC DRIVE IN OBSTRUCTIVE SLEEP APNEA SYNDROME: 2D.04 (2011) (0)
Importance of Consistent 24‐Hour Blood Pressure Control (2000) (0)
4.31 Spontaneous Baroreflex Sensitivity is Reduced in Patients with Recurrent Symptomatic Atrial Fibrillation (2007) (0)
[Hemodynamic changes during fighting behavior in cats. 3. Preparation for the fight]. (1968) (0)
Highlights of the July issue. (2021) (0)
EFFECTS OF OBESITY ON SYMPATHETIC NERVE TRAFFIC VARIABILITY AND ITS BAROREFLEX MODULATION: 8B.2 (2004) (0)
EFFECTS OF HYPOBARIC HYPOXIA AT HIGH ALTITUDE ON HUMORAL REGULATION OF BLOOD PRESSURE AND BODY FLUIDS. RESULTS OF HIGHCARE PROJECT: 5C.03 (2010) (0)
[OP.6A.02] 24-HOUR SYSTOLIC BLOOD PRESSURE LOAD REPRESENTS AN IMPORTANT VARIABLE IN DETERMINING THE CARDIOVASCULAR RIK PROFILE OF WHITE-COAT HYPERTENSION (2017) (0)
Short- and long-term goals in the treatment of hypertension: Concluding remarks (1993) (0)
EFFECTS OF BARIATRIC SURGERY ON INSULIN SENSITIVITY AND SYMPATHETIC NERVE TRAFFIC IN OBESE SUBJECTS. A LONGITUDINAL STUDY: 1D.04 (2011) (0)
Common carotid artery distensibility in aortic banding-induced hypertension (1998) (0)
The need for sustained blood pressure control (1997) (0)
Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: a Prospective Cohort Study. (2023) (0)
EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE (2019) (0)
PP.18.21: ESTIMATION OF LOCAL VASCULAR DAMAGE ASSESSED BY CAROTID-RADIAL PULSE WAVE VELOCITY IN PATIENTS TREATED WITH CHEST RADIOTHERAPY (2015) (0)
Effects of diabetes mellitus on the sympathetic and baroreflex alterations in heart failure (2006) (0)
[67] DIASTOLIC FUNCTION EVALUATED BY TISSUE DOPPLER ANALYSIS AND ARTERIAL STIFFNESS AFTER CARDIAC REVASCULARIZATION (2009) (0)
CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) (0)
7.4 Lack of Association between Serum Uric Acid and Organ Damage in a Never Treated Essential Hypertensive Population at Low Prevalence of Hyperuricaemia (2007) (0)
5.3 Left Ventricular Mass Independently Contributes to Long-Term Risk of Cardiovascular Morbidity and Mortality in a General Population: Data From the PAMELA Study (2008) (0)
[Variability of arterial blood pressure: importance, mechanisms and clinical significance]. (1988) (0)
Highlights of the October issue. (2019) (0)
Highlights of the December issue. (2018) (0)
Continuous positive airway pressure increases haemoglobin O 2 saturation after acute but not prolonged altitude exposure on behalf of the HIGHCARE Investigators (2010) (0)
The CRACK programme: a scientific alliance for bridging healthcare research and public health policies in Italy (2013) (0)
Sympathoadrenergic deactivation and endothelin-1 (ET-1) release are prominent features of rapid total paracentesis (RTP) in cirrhotics with tense ascites (1995) (0)
New aspects of antihypertensive treatment. Metabolism, the kidney and the heart. (1993) (0)
ACE-INHIBITORS AND CARDIOPROTECTION OPEN ISSUES AND FUTURE SOLUTIONS Summary of Presentations from the Menarini Symposium , ESC Annual Congress 2013 , Amsterdam , the Netherlands Chairperson (2013) (0)
[The pneumatic collar in the study of the human carotid baroreceptor reflex]. (1976) (0)
Round table discussion: what blood pressure to measure? (1991) (0)
[Round table on Hypertension and coronary heart disease: new trends in treatment]. (1984) (0)
Health-economic issues in cardiovascular disease : proceedings of a symposium held in Munich, 8 September 1994 (1996) (0)
Long term response (LTR) to interferon monotherapy (IFN-Mon) revisited: unearthing interferon breakthrough in the age of ribavirin combination therapy for chronic hepatitis C (2002) (0)
Selected Abstracts from the National Congress of the Italian Society of Hypertension (SIIA 2012) (2012) (0)
Response to Long-Term Risk in Subjects With White-Coat Hypertension (2009) (0)
Comprar Special Issues in Hypertension | Adel E. Berbari | 9788847026001 | Springer (2012) (0)
Vasomotor control from vagal afferent in dogs (1973) (0)
spontaneous baroreflex in healthy subjects Effects of positive-pressure ventilation on the (2015) (0)
POST HOC ANALYSIS : USE AND DANGERS IN PERSPECTIVE. DISCUSSION (1996) (0)
PP.21.31: COMPARISON OF THE EFFECTS OF TWO DIFFERENT ANTIHYPERTENSIVE DRUG COMBINATIONS ON ARTERIAL DISTENSIBILITY AND PULSE WAVE VELOCITY IN ELDERLY PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION (2015) (0)
ISOLATION OF A QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 18 INFLUENCING VARIABILITY OF BP AND PULSE INTERVAL IN SODIUM LOADED SPONTANEOUSLY HYPERTENSIVE RATS: 9D.09 (2011) (0)
Highlights of the September issue. (2020) (0)
Highlights of the February issue. (2020) (0)
[Mechanism of action of digitalis in humans. Potentiation of reflexes]. (1981) (0)
[OP.4B.08] PROGNOSTIC RELEVANCE OF ELECTROCARDIOGRAPHIC TP-TE INTERVAL IN THE GENERAL AND IN THE HYPERTENSIVE POPULATION: DATA FROM THE PAMELA STUDY (2016) (0)
[Arterial hypertension. Research, progress, hypotheses in the 1970's]. (1981) (0)
[Hemodynamic changes during spontaneous changes of posture in the cat]. (1968) (0)
508 EFFECT OF ANTIHYPERTENSIVE TREATMENT ON MORNING BLOOD PRESSURE SURGE. DETAILED ASSESSMENT BY COMBINATION OF 24 H AMBULATORY BLOOD PRESSURE MONITORING AND POLYSOMNOGRAPHY (2012) (0)
METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
[PP.26.15] COMPARISON OF A NEW FIRST-LINE STRATEGY WITH SPECIALLY ADAPTED DOSAGES OF PERINDOPRIL AND AMLODIPINE WITH ARB MONOTHERAPY (2016) (0)
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials (2023) (0)
Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities (2009) (0)
Effects of metabolic syndrome on the structural and functionl characteristic of subcutaneous small arteries in man (2006) (0)
Secondary Hypertension (2020) (0)
An insight into the mechanisms underlying the sympathoinhibition of acromegaly (2012) (0)
EFFECTS OF BODY FAT ON THE NEUROADRENERGIC ABNORMALITIES OF RENAL FAILURE PATIENTS: 8D.02 (2010) (0)
9.5 Impact of Antihypertensive Treatment on Long-Term Risk of Diabetes Mellitus in a General Population Setting: Data from the PAMELA Study (2008) (0)
Ambulatory blood pressure monitoring in elderly hypertensive patients. (1993) (0)
CONTRIBUTION OF BODY BUILD TO THE DEVELOPMENT OF NEW ONSET DIABETES MELLITUS, HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY: 9B.06 (2010) (0)
ANGIOTENSIN CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM IS RELATED TO PRESSOR RESPONSE TO HIGH ALTITUDE HYPOXIA. RESULTS OF HIGHCARE PROJECT: PP.21.330 (2010) (0)
Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37:1353–1359 (2015) (0)
[Hemodynamic changes during fighting behavior. IV. Prolonged struggling]. (1969) (0)
ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
Preface [to Clinical and Experimental Hypertension Vol. 26, Nos. 7 & 8, 2004. Papers from the Proceedings of the 5th WHO/ISH meeting on pathophysiology and prevention of hypertension and cardiovascular disease] (2004) (0)
1199Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk (2019) (0)
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in resistant hypertension: data from the PAMELA Study (2012) (0)
Introduction to the monographic issue "Recent ongoing epidemiological studies in Italy". (2021) (0)
BEHAVIOR OF INDIRECT AND DIRECT INDICES OF SYMPATHETIC ACTIVITY IN RELATION TO SLEEP TIME DURATION IN UNTREATED MILD-TO-MODERATE ESSENTIAL HYPERTENSIVES (2019) (0)
[[Antihypertensive therapy and organ protection]. (1996) (0)
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS (2019) (0)
AUTONOMIC INDEXES OF HEART RATE VARIABILITY AND BLOOD PRESSURE VARIABILITY ARE SIMILARLY ALTERED IN CONGESTIVE HEART FAILURE AND CORONARY ARTERY DISEASE PATIENTS, INDEPENDENTLY FROM THEIR EJECTION FRACTION: PP.28.388 (2011) (0)
[Some considerations on long-acting vascular drugs]. (1992) (0)
Increased Arterial Stiffness in Normoglycemic Normotensive Offspring of Type 2 Diabetic Parents. Commentary (2008) (0)
COGNITIVE FUNCTION UNDER EXPOSURE TO HYPOBARIC HYPOXIA AT ALTITUDE: DATA FROM THE HIGHCARE PROJECT: PP.4.136 (2010) (0)
[BP.10.04] NORMALIZATION OF SYMPATHETIC NERVE TRAFFIC IN THE LONG TERM FOLLOW-UP AFTER BAROREFLEX ACTIVATION THERAPY IN HEART FAILURE PATIENTS: FINAL STUDY REPORT. (2017) (0)
Renin Academy in focus (2005) (0)
SEASONAL CHANGES AND MORNING BLOOD PRESSURE SURGE. WHICH ROLE FOR OUTDOOR AND INDOOR AIR TEMPERATURE?: PP.29.147 (2010) (0)
A reverse translational pharmacological approach to understand the underlying mechanisms of the reported association between hydrochlorothiazide and non-melanoma skin cancer (2022) (0)
Home Blood Pressure and Preclinical Organ Damage (2019) (0)
Evidence in favour of ambulatory blood pressure grows but gaps in knowledge remain (2023) (0)
ADVANCE: a new era in diabetes and hypertension. Introduction. (2008) (0)
Chapter 11 – Secondary Hypertension: Sleep Apnea (2012) (0)
Cardiovascular endocrinology: Tailoring antihypertensive drug treatment to body size (2013) (0)
RISK OF NEW ONSET METABOLIC SYNDROME ASSOCIATED WITH SELECTIVE AND COMBINED ELEVATION IN OFFICE, HOME AND AMBULATORY BLOOD PRESSURE (2018) (0)
1129 IRON OVERLOAD INCREASES SYMPATHETIC NERVOUS ACTIVITY: STUDY IN HEMOCHROMATOSIS PATIENTS AT DIAGNOSIS AND IRON DEPLETION (2010) (0)
Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network (1998) (0)
ESTIMATE OF 24-HOUR MEAN AND STANDARD DEVIATION (SD) BY INTERMITTENT SAMPLING OF BLOOD PRESSURE SEGMENTS. (1987) (0)
[OP.7B.02] LONG TERM CHANGES IN LEFT VENTRICULAR MASS: ECHOCARDIOGRAPHIC FINDINGS FROM A GENERAL POPULATION (THE PAMELA STUDY) (2017) (0)
Expert Answers to Three Key Questions What are the mechanisms of stroke ? - (2005) (0)
A farewell from the Milan editorial team. (2021) (0)
Sympathoinhibitory effects of total paracentesis (TP) in cirrhosis: microneurographic studies (1998) (0)
MEASUREMENTS OF CAROTID ARTERY DISTENSIBILITY BY SIMULTANEOUS ASSESSMENT OF CAROTID DIAMETER AND PRESSURE WAVEFORMS: P1.129 (2004) (0)
Endothelium in polycythemia secondary to obstructive lung disease. (2011) (0)
This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Role of Tissue Doppler Imaging for Detection of Diastolic Dysfunction in the Elderly A Study in Clinical Practice (2011) (0)
Spotlight: Giuseppe Mancia, MD, PhD. Interview by Emma Baines. (2007) (0)
CLINIC AND 24 H LONG-TERM BLOOD PRESSURE (BP) VARIABILITY IN NON BETA-BLOCKER AND BETA-BLOCKER-TREATED HYPERTENSIVE PATIENTS. DATA FROM ELSA TRIAL: 6C.08 (2011) (0)
BLOOD PRESSURE CONTROL BY CAROTID SINUS BARORECEPTORS IN MAN (1981) (0)
Successful perindopril/amlodipine+indapamide treatment as second line in uncontrolled hypertensive patients in line with european guidelines (2022) (0)
Highlights of the May issue. (2019) (0)
Clinical signiﬁcance of diabetes likely induced by statins: Evidence from a large population-based cohort (2017) (0)
Vasodilating properties of dilevalol (1989) (0)
[BP.07.05] ASSOCIATION BETWEEN URIC ACID AND CARDIAC, VASCULAR AND RENAL TARGET ORGAN DAMAGE IN HYPERTENSIVES SUBJECTS. (2017) (0)
Highlights of the February issue. (2018) (0)
Summary: The therapeutic potential of third-generation β-adrenergic receptor blockers (1989) (0)
ARM AND WRIST AUTOMATED OSCILLOMETRIC SPHYGMOMA-NOMETERS: A NEW APPROACH TO DIAGNOSE PSEUDOHYPERTENSION IN THE ELDERLY (2004) (0)
IS ANTIHYPERTENSIVE TREATMENT PROTECTIVE IN ELDERLY FRAIL PATIENTS? EVIDENCE FROM AN ITALIAN REAL-WORLD POPULATION (2019) (0)
PP.21.34: EXTENSIVE DEVELOPMENT OF A NEW ANTIHYPERTENSIVE STRATEGY A SINGLE-PILL COMBINATION INDICATED AS FIRST LINE THERAPY (2015) (0)
Slow Breathing Improves Gas Exchange in Subjects Exposed to High Altitude Related Hypoxia: 6.8 (2005) (0)
Response to nondipping and cardiovascular risk after morning renin–angiotensin blockade. (2013) (0)
[Characteristics of vasodilation in the region of the external iliac artery during stretching and other types of spontaneous movement of the hindlimb, in non-anesthetized cats]. (1969) (0)
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE. (2022) (0)
Noninvasive Methods for Arterial Stiffness Measurement Systemic Determination of Arterial Stiffness (2002) (0)
[Changes in the compliance of the radial artery in normotensive subjects with familial hypercholesterolemia]. (1995) (0)
Highlights of the June issue. (2019) (0)
PHERIPHERAL BENZODIAZEPINE RECEPTORS IN LYMPHOCYTES OF ESSENTIAL HYPERTENSIVE PATIENTS (1995) (0)
Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy (2016) (0)
P2650Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: relationship with all-cause mortality (2019) (0)
Highlights of the October issue. (2020) (0)
Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents (2023) (0)
P3405Association between heart rate thresholds for cardiovascular risk defined by new ESC/ESH Guidelines and neuroadrenergic markers (2019) (0)
OFFICE, HOME AND AMBULATORY BLOOD PRESSURE LONG-TERM CHANGES IN THE GENERAL POPULATION (2019) (0)
Highlights of the March issue. (2019) (0)
[Arterial hypertension and myocardial infarction]. (1993) (0)
The case for calcium anatognists as first-line treatment of hypertension. Discussion (1992) (0)
Consensus Document European Society of Hypertension practice guidelines for ambulatory blood pressuremonitoring (2014) (0)
CAN MOUNTAIN SICKNESS SYMPTOMS BE PREDICTED ON THE BASIS OF BLOOD COAGULATION PARAMETERS?: 9A.04 (2010) (0)
Correction: New-onset aortic dilatation in the population: a quarter-century follow-up. (2022) (0)
Zofenopril: Blood pressure control and cardio-protection (2021) (0)
4.3 Alterations in Cardiac Structure in Nondiabetic Offsprings of Diabetic Patients (2007) (0)
[Protocol-guide in clinical experimentation on vasodilator agents in chronic cardiac failure]. (1985) (0)
with analysis of intra-arterial recordings Spectral and sequence analysis of finger blood pressure variability. Comparison (2011) (0)
[108] INTRARENAL RESISTANCE INDICES ARE RELATED WITH ARTERIAL STIFFNESS AND OTHER SUBCLINICAL CARDIOVASCULAR RISK FACTORS (2009) (0)
CLINICAL AND AMBULATORY BLOOD PRESSURE (BP) VALUES IN CENTENARIES: PP.16.110 (2010) (0)
Highlights of the issue. (2018) (0)
Highlights of the April issue. (2021) (0)
PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY ACCORDING TO ESC AND ACC CRITERIA IN ESSENTIAL HYPERTENSION: PP.22.381 (2010) (0)
Highlights from International Congress (2008) (0)
11.1 Cost and Prescription of Antihypertensive Therapy in Region Lombardia Between 2004/2006: Fixed Combinations as Savings Opportunities (2008) (0)
White Coat Hypertension and Cardiovascular Morbidity and Mortality (2015) (0)
Remodeling of Resistance Arteries and Endothelial Function in Patients with Severe Abdominal Obesity: 9.32 (2005) (0)
Pulmonary arterial hypertension and arterial stiffness (2011) (0)
The Global SYMPLICITY Registry: Safety and Efficacy Report (2017) (0)
Abstract P446: External Validation Of The CAMUNI Score, A Long-term Cvd Prediction Equation For Low-incidence Populations. (2014) (0)
Economic and organizational issues (2008) (0)
10.10 Nuclear Magnetic Resonance Evaluation of Aortic Distensibility in Essential Hypertensive Patients (2007) (0)
ADVANCE in the Prevention of Cardiovascular Disease in Diabetic Patients (2007) (0)
Effects of the Metabolic Syndrome on the Sympathetic and Baroreflex Alterations in Heart Failure: 4.13 (2005) (0)
High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus (2013) (0)
[Reflex influences on renal secretion of renin in essential hypertension]. (1977) (0)
[Regional hemodynamics during desynchronized sleep in the cat]. (1968) (0)
Cardiovascular Effects of Acute and Prolonged Hypobaric Hypoxia in Healthy Subjects: 7.8 (2005) (0)
Highlights of the January issue. (2019) (0)
Highlights of the April issue. (2019) (0)
Non-invasive ambulatory blood pressure monitoring: Introduction (1990) (0)
AMBULATORY BLOOD PRESSURE VARIABILITY IN NORMOTENSION AND IN WHITE COAT, MASKED AND SUSTAINED HYPERTENSION. DATA FROM THE SPANISH AMBULATORY BLOOD PRESSURE REGISTRY: PP.3.100 (2010) (0)
News, Reminiscences and Perspectives: a new section of the Journal of Hypertension (2002) (0)
C006: Isolated office hypertension (white coat hypertension) (IOH) in a general population. the PAMELA study (2000) (0)
Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease... (2015) (0)
Highlights of the December issue. (2020) (0)
[LB.02.09] EARLY CARDIOVASCULAR PROTECTION BY COMBINATION VS MONOTHERAPY IN HYPERTENSION (2017) (0)
[Evaluation of sympathetic nervous activity in humans]. (1990) (0)
Review for "Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta‐Analysis" (2019) (0)
IS BLOOD PRESSURE REDUCTION SUFFICIENT TO INDUCE REGRESSION OF HYPERTENSION-RELATED VASCULAR STRUCTURAL CHANGES?: P3.120 (2000) (0)
In Memoriam: professor Antonio Salvetti (1936-2021). (2021) (0)
Angiotensin II receptor blockade: vascular and organ protective effects - Proceedings of an international workshop held in Gouvieux-Chantilly, France, 28-30 April 2005 - Introduction (2006) (0)
An Unexpected Cause of Severe Hypertension and Bradycardia: The Role of Hemodynamic Assessment by Echocardiography (2022) (0)
The Pamela Study: Old and New Findings (2011) (0)
C029: Seasonal variations in clinic, home and ambulatory blood pressure (1998) (0)
Transdermal treatment with clonidine—a new approach in the management of hypertension (1993) (0)
A PRACTICAL APPROACH TO SWITCH FROM A MULTIPLE PILL THERAPEUTIC STRATEGY TO A POLYPILL-BASED STRATEGY FOR SECONDARY PREVENTION IN PATIENTS WITH HYPERTENSION (0)
Epidemiology of cardiovascular disease in the region Middle East as a whole (2012) (0)
Correlation between left ventricular mass and blood pressure in patients aged over 90 years (2010) (0)
CHRONIC ALTERATIONS OF LEFT VENTRICULAR FUNCTION AND STRUCTURE INTERFERONE (IFN) TREATMENT IN HCV + CHRONIC ACTIVE EPATITIS (CHA): 6C.5 (2000) (0)
INCREASED LEFT VENTRICLE APICAL ROTATION UNDER EXPOSURE TO HYPOBARIC HYPOXIA AT VERY HIGH ALTITUDE: A SIGN OF SUBENDOCARDIAL ISCHEMIA? DATA FROM THE HIGHCARE PROJECT: 3D.08 (2011) (0)
Reply. (2021) (0)
DOES USE OF ANTIHYPERTENSIVE TREATMENT TO REDUCE ALBUMINURIA TRANSLATE INTO EFFECTIVE BENEFITS ON OUTCOME AND MORTALITY? A REAPPRAISAL OF STUDIES WITH RENAL ENDPOINTS IN DIABETES: PP.16.105 (2010) (0)
Erratum to: Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study (2015) (0)
NEUROADRENERGIC OVERDRIVE IN THE METABOLIC SYNDROME (2019) (0)
Editorial: Uncontrolled Hypertension and Related Comorbidities: A Clinician's Update. (2017) (0)
Left ventricular mass and incident out-of-office hypertension in a general population. (2019) (0)
Microcirculation in Cardiovascular Diseases (2020) (0)
[Hypotensive action of clonidine and baroreceptor reflexes in essential hypertension]. (1977) (0)
TCTAP A-002 Long-Term Safety and Efficacy of Renal Denervation in the Global Symplicity Registry Using the Symplicity Spyral Catheter (2023) (0)
Prevention and Treatment of Heart Failure in Hypertension Guidelines (2019) (0)
HETEROGENEITY IN DISCONTINUATION OF ANTIHYPERTENSIVE TREATMENT BETWEEN DRUGS FROM THE SAME CLASS: PS.3.02 (2010) (0)
Arterial Structure and Function are Influenced By Antiretroviral Therapy and by the Presence of Renal Damage in HIV Positive Patients (2010) (0)
992 / 3-Adrenergic Blocking Treatment and 24-Hour Baroreflex Sensitivity in Essential Hypertensive Patients (2005) (0)
NIGHT-TIME HEART RATE NON DIPPING: CLINICAL AND PROGNOSTIC SIGNIFICANCE IN THE GENERAL POPULATION (2018) (0)
Heart Rate, Stroke Volume and Vasomotor Regulation in the Cat during Exertion and Postural Changes * (1970) (0)
Tissue characterization of carotid wall in mildly diseased arteries: comparison of videodensitometric analysis and integrated backscatter (2007) (0)
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
4.1 Effects of Left Ventricular Diastolic Dysfunction on Neuroadrenergic and Baroreflex Alterations in Essential Hypertension (2007) (0)
Type 2 Diabetes Mellitus Resting Heart Rate and the Risk of Microvascular Complications in Patients With Copyright (2012) (0)
11.9 Differences between ACE Inhibitor and Angiotensin II Receptor Blocker-based therapy in preventing myocardial infarction, stroke and cardiovascular mortality: a meta-analysis (2008) (0)
[Can determination of catecholamines in the blood reflect slight changes in sympathetic activity?]. (1980) (0)
Continuous non-invasive finger blood pressure recording by the FINAPRES device: A new approach to beat-to-beat blood pressure monitoring (1989) (0)
Total paracentesis does not impair nutritional status in cirrhotic patients with tense ascites (1998) (0)
BLOOD PRESSURE CONTROL IN TREATED HYPERTENSIVES: RESULTS FROM DIGIT (STUDIO ITALIANO SULLA GESTIONE DELL'IPERTENSIONE) A LARGE OBSERVATIONAL STUDY ON ITALIAN TREATED HYPERTENSIVES: 4A.07 (2010) (0)
EFFECTS OF SINGLE OR MULTIPLE DRUG THERAPIES ON CARDIOVASCULAR OUTCOMES IN HYPERTENSION: ANALYSIS OF DATA FROM THE VALUE TRIAL: 6C.04 (2011) (0)
Myocardial Tissue Characterization by Integrated Backscatter Analysis in Chronic Heart Failure: 4.9 (2005) (0)
10.9 Changes of IMT and Arterial Stiffness in Subclinical Sleep Apnoea (2007) (0)
Symposium on the Prevention of Hypertension and Cardiovascular Disease: Introduction (1992) (0)
1.15 Different Relationship of Night-Time and Daytime Blood Pressure with Arterial Stiffness in Treated Hypertensive Subjects (2007) (0)
The metabolic syndrome and antihypertensive treatment in the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (0)
Primary and secondary prevention of stroke (2003) (0)
In Memoriam: professor Antonio Salvetti (1936-2021). (2021) (0)
COST-EFFECTIVENESS CALCULATIONS FROM TRIALS. DISUCUSSION (1996) (0)
Effects of Cold Pressor Test and Diving on Systemic and Coronary Hemodynamics in 19 Subjects Cold pressor test Diving Baseline A Baseline A MAP (2005) (0)
Arterial disorders: Definition and epidemiology (2015) (0)
Williams syndrome is associated with an increase in heart rate and wave reflection values during the nighttime period. (2012) (0)
2.3 Prevalence of the Metabolic Syndrome in HIV Patients (2007) (0)
24-Hour Blood Pressure and Stroke (1994) (0)
Blood pressure levels on progression of coronary atherosclerosis. Authors' reply (2007) (0)
Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure (2022) (0)
[PP.33.03] PREVALENCE AND CORRELATES OF NEW-ONSET LEFT VENTRICULAR GEOMETRIC ABNORMALITIES IN A GENERAL POPULATION: THE PAMELA STUDY (2016) (0)
Highlights of the November issue. (2019) (0)
Proceedings of the Symposium: ‘A straightforward strategy for all grades of hypertension’ (2005) (0)
HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): AORTIC STIFFNESS, BIOHUMORAL MARKERS AND ECHOCARDIOGRAPHIC EVALUATION: 4C.04 (2011) (0)
[Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect]. (1999) (0)
Renal artery flows during pregnancy in normotensive pre-eclamptic abd hypertensive women : a preliminary report (2002) (0)
8B.02: EFFECTS OF LONG-TERM BAROREFLEX ACTIVATION IN CONGESTIVE HEART FAILURE (2015) (0)
P-414: Sympathetic nerve traffic responses to premature ventricular contractions in essential hypertension and congestive heart failure (2002) (0)
Ambulatory Blood Pressure Monitoring (2012) (0)
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial: Erratum (2014) (0)
A Tool for Better Hypertension Control (2010) (0)
Chapter 52 – European and British Guidelines on Hypertension (2012) (0)
Foreword. Calcium antagonists in the prevention of cardiovascular disease: past, present and future (2009) (0)
[Hemodynamic changes during fighting behavior in cats. I. Fighting in erect posture]. (1968) (0)
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension (2009) (0)
Comparing methods for asses sing cardiovascular risk (2009) (0)
AMBULATORY BLOOD PRESSURE VALUES AND 24-HOUR BLOOD PRESSURE PROFILE IN ULTRACENTENNIAL HUMAN BEINGS: 1B.5 (2000) (0)
Contribution of the Metabolic Factors on the Sympathetic Overactivity Characterizing Human Obesity: 6.6 (2005) (0)
Key questions regarding the SYMPLICITY HTN-3 trial (2023) (0)
E126 Comparison of the antihypertensive efficacy of ace-inhibitors treatment combined with a diuretic or a calcium antagonist by ambulatory blood pressure monitoring (1998) (0)
Erratum: Systolic blood pressure and pulse pressure: Role of 24-h mean values and variability in the determination of organ damage (Journal of Hypertension (1999) 17, Suppl. 5) (2000) (0)
Long term antihypertensive treatment and its effect on 24 hour blood pressure profile (1997) (0)
ASSESSING WHITE COAT EFFECT: DIFFERENT BLOOD PRESSURE MEASURES YIELD DIFFERENT RESULTS (2000) (0)
INDEXING CARDIAC PARAMETERS IN ECHOGRAPHIC PRACTICE: DO ESTIMATES DEPEND ON HOW WEIGHT AND HEIGHT HAVE BEEN ASSESSED? A STUDY ON LEFT ATRIAL DILATATION: PP.23.210 (2011) (0)
Factors Determining Left Ventricular Structure in Male and Female Hypertensive Patients: Not Only Ambulatory Blood Pressure (2005) (0)
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study (2011) (0)
Arterial Baroreflexes in Normotensive and Hypertensive Man (1982) (0)
[Study of arterial distensibility in man. Modulating mechanisms, pathological conditions and effects of treatment]. (2003) (0)
CARDIO-RESPIRATORY ADAPTATION TO HIGH ALTITUDE HYPOXIA IN PROFESSIONAL CLIMBERS VERSUS NON-CLIMBERS. THE HIGHCARE PROJECT: PP.32.277 (2010) (0)
Treatment allocation for primary cardiovascular disease prevention based on long-term CVD risk prediction: insights from the Brianza cohort study in Northern Italy (2013) (0)
Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the Lombardy Database (2018) (0)
White Coat Hypertension, Metabolic Risk Factors and Cardiovascular Risk Profile (2015) (0)
Contents (2020) (0)
Arterial Hypertension 2007 (2012) (0)
Portal pressure lowering effects of aldosterone antagonism in postviral preascitic child a cirrhosis with small oesophageal varices is not matched with sympathoinhibition (2003) (0)
VALUE OF ECHOCARDIOGRAPHIC AND AMBULATORY BLOOD PRESSURE (1989) (0)
Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian database (2022) (0)
Impairment of Arterial Distensibility in Diastolic Heart Failure: 9.27 (2005) (0)
Highlights of the August issue. (2020) (0)
WOMEN DISCONTINUE ANTIHYPERTENSIVE DRUG THERAPY MORE THAN MEN (2019) (0)
hypertensive subjects Carotid sinus baroreceptor control of arterial pressure in renovascular (2011) (0)
Neuro-adrenergic and reflex abnormalities in hypertensive patients with heart failure (2000) (0)
The rationale, protocol and preliminary results of the ESH ABPM COVID-19 study. (2022) (0)
EFFECTS OF HYPOBARIC HYPOXIA AT HIGH ALTITUDE ON OXIDATIVE STRESS PARAMETERS. RESULTS OF THE HIGHCARE PROJECT: 4B.11 (2011) (0)
Considerations on the PAMELA study results concerning ambulatory blood pressure normality (1996) (0)
Hypertension and receptors: Introduction (1992) (0)
Common carotid and femoral artery mechanical properties in normotensive and spontaneously hypertensive rats (1997) (0)
[PP.05.33] IMMEDIATE REDUCTION OF PULSE WAVE VELOCITY AS A MARKER OF EFFICACY OF RENAL DENERVATION THERAPY IN HEMODIALYSIS PATIENTS WITH RESISTANT HYPERTENSION (2017) (0)
DOUBLE-BLIND PLACEBO CONTROLLED STUDY OF THE EFFECTS OF CLONIDINE TTS ON SYMPATHETIC NERVE TRAFFIC AND ARTERIAL BAROREFLEX IN HEART FAILURE PATIENTS: 6B.2 (2000) (0)
Prevention of Microalbuminuria in Diabetes Mellitus: Results of the ROADMAP Trial (2011) (0)
INCREASED MYOCARDIAL REFLECTIVITY IN HYPERTENSIVE PATIENTS: A PRELIMINARY REPORT (2004) (0)
Sympathetico and metabolic abnormalities in the pre-diabetic state complicationg human obesity (2012) (0)
Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities (2014) (0)
NEUROADRENERGIC OVERDRIVE IN OVERWEIGHT AND OBESITY AND ITS CORRELATES (2019) (0)
Network meta-analyses in hypertension. (2020) (0)
The Italian registry of renal denervation (2013) (0)
Clinical benefits of low frequency respiratory pacing in heart failure patients (2003) (0)
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy (2023) (0)
Response to Seasonal Changes in Blood Pressure: Possible Interaction Between Sunlight and Brain Serotonin (2013) (0)
Highlights of the February issue. (2021) (0)
Evaluation of end-points in hypertension (1997) (0)
[LB.02.04] EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP DATA OF 3 YEARS (2017) (0)
Oral Sessions (2020) (0)
parabolic flight Orthostatic intolerance and motion sickness after (2015) (0)
P-546: Reduction of pulmonary pressure values after pge1 infusion in sclerodermic patients with pulmonary involvement (2002) (0)
BLOOD PRESSURE MONITORING AND LVM IN CENTENARIANS: PP.17.66 (2011) (0)
7.4 Early Cardiac Damage in High Cardiovascular Risk Patients (2008) (0)
Endothelial function and cardiovascular disease in humans, Proceedings of a satellite symposium to the VIII European Meeting on Hypertension, Camogli, Italy, 8-9 June 1997; Introduction (1998) (0)
Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. (2020) (0)
Clinical trials with ambulatory monitoring : evidence from the Syst-Eur Trial (1995) (0)
MO085: 10-Year Clinical Events Avoided in Diabetic and Chronic Kidney Disease Hypertension Patients Treated With Radiofrequency Renal Denervation: Projections Based on 3-Year Data From the Global Symplicity Registry (2022) (0)
Highlights of the September issue. (2019) (0)
6.3 Regional Patterns of Adrenergic Overdrive in Mild Renal Failure: Relations with Metabolic and Cardiac Abnormalities (2007) (0)
Managing coronary heart disease risk in hypertensive smokers: Summary (1990) (0)
PS-C36-6: REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF THE QUADRUPLE COMBINATION PERINDOPRIL, INDAPAMIDE, AMLODIPINE AND BISOPROLOL IN ITALY (2023) (0)
ECG criteria for left ventricular hypertrophy and twenty-four-hour ambulatory blood pressure in the Syst-Eur study (1991) (0)
S-12-1: PAST AND FUTURE OF HYPERTENSION RESEARCH (2023) (0)
Highlights of the January issue. (2021) (0)
Metabolic syndrome and biventricular hypertrophy in essential hypertension. Commentary (2009) (0)
[Hemodynamics of the emotional behavior of the cat]. (1969) (0)
Seasonal influences on ambulatory blood pressure. An insight from the HARVEST study (multiple letters) [2] (1999) (0)
In memoriam: Peter Sleight 1929-2020. (2020) (0)
Uric Acid-Hypertension Relationships (2018) (0)
[Reflex control of arterial pressure in the non-anesthetized cat]. (1980) (0)
Safety and efficacy of sildenafil citrate in men with erectile dysfunction and hypertension who are taking multiple antihypertensive treatments (2003) (0)
[OP.1A.08] PROGNOSTIC RELEVANCE OF RESTING HEART RATE IN OBESITY: LONGITUDINAL EVIDENCE FROM THE PAMELA STUDY (2017) (0)
STUDY OF THE EUROPEAN SOCIETY OF HYPERTENSION ON BLOOD PRESSURE CONTROL IN ESH EXCELLENCE CENTERS (BP CON ESH) - THE FIRST PRELIMINARY REPORT (2021) (0)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension^Chinese Hypertension League Stroke in Hypertension OptimalTreatment randomized trial (2014) (0)
[Hemodynamic changes present during muscular exercise limited to the anterior part of the body, in cats]. (1969) (0)
Comprar Cardiorenal Syndrome | Berbari, Adel E. | 9788847014626 | Springer (2010) (0)
Into Complex Physiology Assessing the Sensitivity of Spontaneous Baroreflex Control of the Heart: Deeper Insight (2013) (0)
[Variability of heart rate in hypertensive patients: clinical and physiopathological implications]. (1994) (0)
[PP.26.16] INDIVIDUAL DATA META-ANALYSIS IN 5507 SUBJECTS OF PERINDOPRIL 3.5 MG/AMLODIPINE 2.5 MG IN COMPARISON WITH RAS BLOCKER- MONOTHERAPIES (2016) (0)
[OP.7A.01] THE GLOBAL SYMPLICITY REGISTRY: SAFETY AND EFFICACY REPORT (2017) (0)
A071: Effects of lercanidipine on forearm and calf vascular structural changes in hypertension (2000) (0)
The new concept of total cardiovascular risk management (2011) (0)
Theme II: debate: ambulatory blood pressure monitoring should be routine in clinical management : Ambulatory blood pressure monitoring (ABPM) should be routinely performed. A critical view. (1999) (0)
S-17-3: ANTIDIABETIC DRUG THERAPY AND SURVIVAL IN ELDERLY FRAIL PATIENTS. REAL-LIFE EVIDENCE FROM ITALY (2023) (0)
COMPARISON OF ESTIMATES OF CENTRAL SYSTOLIC BLOOD PRESSURE OBTAINED FROM THE BPRO AND SPHYGMOCOR SYSTEMS (2009) (0)
PL 01-1 CARDIOVASCULAR PROTECTION IN HYPERTENSION. WHICH TARGETS FOR TREATMENT. (2016) (0)
Highlights of the October issue. (2018) (0)
Presidential Address (1982) (0)
A new dawn in cardio and vascular protection v. cardiovascular high-risk patients: treat to protect. (2008) (0)
erythropoiesis in humans in vivo: data from the HIGHCARE project Modulation of hepcidin production during hypoxia-induced (2012) (0)
CLINICAL IMPLICATIONS FOR THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN HYPERTENSION: S4 (2004) (0)
Clinical implications of differences between angiotensin II antagonists (1998) (0)
273Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients (2017) (0)
Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
Who is an expert? Reply (2017) (0)
[Angiotensin II receptor antagonists in arterial hypertension: new clinical evidence with candesartan]. (1999) (0)
Coronary heart disease prevention task force - Reply. (1999) (0)
Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial (2012) (0)
A Trial Involving HIV-Tuberculosis in India (2010) (0)
Therapy, Pharmacoeconomics and Pharmacovigilance (2008) (0)
P-18: Comparative effects of lercanidipine and hydrochlorothiazide on hypertension-related cardiac and vascular structural alterations (2002) (0)
PP.07.31: COMPARISON OF A NEW FIRST-LINE SINGLE-PILL COMBINATION STRATEGY VERSUS A CLASSIC STEPPED-CARE STRATEGY IN HYPERTENSION USING 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING (2015) (0)
increases lung diffusing capacity in humans High-altitude exposure of three weeks duration (2015) (0)
Effects of acetazolamide on blood pressure and pulse waveform changes induced by high altitude exposure (2011) (0)
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS). (2022) (0)
Angiotensin receptor blockers and myocardial infarction : the importance of dosage. Authors' reply (2006) (0)
Blood pressure levels on progression of coronary atherosclerosis. (2007) (0)
24h beat-to-beat blood pressure and heart rate modulation in Cushing's disease before and after pituitary surgery (2000) (0)
[Systolic cardiac output and minute-volume during natural sleep in the cat. Preliminary research with implanted electromagnetic flowmeters]. (1966) (0)
Highlights of the March issue. (2020) (0)
S-10-3: CAN ACHIEVED AVERAGE SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG CAUSE HARM IN ELDERLY HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY? (2023) (0)
Etiological and pathophysiological aspects (2008) (0)
Lacidipine in the Treatment of Hypertension: Clinical Data (1993) (0)
Autonomic abnormalities in hypertension (2008) (0)
NEW ONSET DIABETES MELLITUS IN RANDOMISED CLINICAL TRIALS PERFORMED WITH ACE INHIBITORS OR ANGIOTENSIN II RECEPTOR BLOCKERS: AN UPDATED META-ANALYSIS VERSUS PLACEBO: PP.27.88 (2010) (0)
537 Portal-pressure gradient reduction by K-canrenoate is not parallelled by sympathoinhibition in postviral preascitic child a cirrhosis with small oesophageal varices (2003) (0)
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up (2016) (0)
Autonomic Nervous System Dysfunction and Risk of Stroke (2017) (0)
Highlights of the July issue. (2019) (0)
Invited review Therapeutic strategies to lower and control high blood pressure (2009) (0)
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. (2019) (0)
Highlights of the November issue. (2018) (0)
Highlights of the March issue. (2019) (0)
Residual Risk in Treated Patients (2019) (0)
5.2 Myocardial Integrated Backscatter in Normotensive and Hypertensive Diabetic Patients (2008) (0)
NEW ONSET LEFT ATRIAL ENLARGEMENT IN A GENERAL POPULATION. DATA FROM THE PAMELA STUDY: LB1.5 (2011) (0)
[Hemodynamic changes during muscular exercise in cats]. (1969) (0)
9.1 Pro-Arrhythmogenic Role of Sympathetic Activation and Baroreflex Dysfunction in Human Obesity (2008) (0)
Calcium antagonists and sympathetic activity in congestive heart failure. (1998) (0)
ROLE OF SYMPATHETIC AND BAROREFLEX MECHANISMS IN THE PATHOPHYSIOLOGY OF THE HYPERTENSIVE DISEASE IN WOMEN: 3C.3 (2004) (0)
Response to Sympathetic Activity, Heart Failure, Obesity, and Metabolic Syndrome: Is There Any Role for Sleep Apnea? (2007) (0)
Narrative update of clinical trials with antihypertensive drugs in children and adolescents (2022) (0)
Association between Berlin questionnaire index and blood pressure, organ damage and metabolic profilein a general population (2022) (0)
Mancia and Parati Clinical Value of Ambulatory Blood Pressure 895 (2000) (0)
Erratum: Prevention and treatment of stroke in patients with hypertension (Clinical Therapeutics (May 2004)) (2004) (0)
Comment on: Guidelines for the treatment of hypertension. Editorial comment (1996) (0)
Early alterations of left ventricular function and structure during INF treatment in HCV+ chronic active hepatitis (CAH). (1999) (0)
Reliability of Blood Pressure Patterns Defined by a Single 24-Hour Ambulatory Blood Pressure Monitoring: The Case of the Dipping/Non Dipping and Isolated Clinic Hypertension (2007) (0)
[Carotid baroreceptor reflex in normotensive subjects and hypertensive patients]. (1976) (0)
[Spanish adaptation of the European guidelines on cardiovascular prevention (and II)]. (2004) (0)
Recent Hypertension Guidelines: Sorting through the Evidence or Lack Thereof (2014) (0)
Cardiac Autonomic Regulation in Vagally-Mediated Atrial Fibrillation: 7.7 (2005) (0)
IMPORTANCE OF MEAN BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY FOR THE EFFECT OF VALSARTAN VERSUS AMLODIPINE ON CARDIOVASCULAR EVENTS AND DEATH (2018) (0)
[Cardiovascular effects of emotional behavior: different responses to various emotional stimuli]. (1971) (0)
9C.07: MULTICENTRE RANDOMISED, DOUBLE BLIND, EVALUATION OF NEBIVOLOL PLUS HCTZ AND IRBESARTAN PLUS HCTZ IN THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY THE NEHIS STUDY (2015) (0)
7.1 Metabolic Syndrome is Characterised by Sympathetic Activation Independently on the Obese State (2007) (0)
The impact of renal denervation procedure on use of antihypertensive drugs in the real-life setting (2022) (0)
ROLE OF PULSE PRESSURE IN DETERMINING HYPERTENSION-RELATED STRUCTURAL VASCULAR ALTERATIONS: P3.119 (2000) (0)
VASOPEPTIDASE-INHIBITOR OMAPATRILAT (1999) (0)
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients (2023) (0)
TCT CONNECT-419 Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Antihypertensive Medication Burden and Changes in Blood Pressure out to 3 Years (2020) (0)
IMPAIRED MIDWALL MECHANICS AND BIVENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSION: PP.22.379 (2010) (0)
Saturday, 17 July 2010 (2010) (0)
1.3 Reproducibility of Dipping/Non Dipping Pattern in Untreated Essential Hypertensives: Impact of Gender and Age (2007) (0)
Hemodynamic and Adrenergic Effects of Cigarette Smoking (1995) (0)
MIDWALL SYSTOLIC FUNCTION IS IMPROVED FOLLOWING REGRESSION OF LEFT VENTRICULAR HYPERTROPHY AND NORMALIZATION OF CHAMBER GEOMETRY: P1.208 (2000) (0)
Highlights of the May issue. (2019) (0)
One hundred years of blood pressure measurement: A tribute to Scipione Riva-Rocci (1996) (0)
Sympathoinhibitory effects of Clonidine TTS in congestive heart failure (2000) (0)
The broadening landscape for hypertension management. (2008) (0)
Effects of somatostatin analogues on muscle sympathetic nerve activity in acromegaly (2013) (0)
[New trends in pharmacotherapy of arterial hypertension]. (1999) (0)
SYMPATHECTOMY-INDUCED RESTORATION Of DEPRESSED BARORECEPTOR-HEART RATE REFLEX IN RATS WITH CONGESTIVE HEART FAILURE: P2.190 (2000) (0)
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study (2014) (0)
10.1 Sympathetic Responses to Ventricular Extrasystolic Beats in Obese Subjects without and with Sleep Apnoea (2008) (0)
New trials needed (2011) (0)
Effects of AT1 Blockers on Left Atrium Dimension and PRO-BNP Levels in Hypertensive Patients: 8.13 (2005) (0)
9.13 Counteracting the Cardiovascular Effects of Hypobaric Hypoxia at Altitude: Role of Selective and Non-Selective Beta-Blockade (2007) (0)
Mechanisms of anti hypertensive effect of beta adrenoceptor blockers in man evidence against potentiation of baro receptor control of circulation (1983) (0)
Prescribing blood pressure lowering drugs irrespective of blood pressure? (2022) (0)
EFFECTS OF ANTIRETROVIRAL THERAPY ON ENDOTHELIAL FUNCTION IN HIV PATIENTS: 4D.01 (2011) (0)
In Memoriam: Alberto Zanchetti (Parma July 27, 1926 – Milan March 24, 2018) (2018) (0)
PS-P07-8: TREATMENT STRATEGIES AND ADHERENCE TO THE TRIPLE COMBINATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, A CALCIUM-CHANNEL BLOCKER, AND A DIURETIC (2023) (0)
Response: How to Measure Blood Pressure Variability (2019) (0)
Influence of cardiovascular risk on the efficacy of antihypertensive treatment in the insight trial (1999) (0)
Optimization of Antihypertensive Drug Treatment in Resistant Hypertension (2016) (0)
H47 Insight: Baseline characteristics (1997) (0)
Sleep Apnoea Syndrome Potentiates the Neuroadrenergic and Metabolic Dysfunction of Patients with Metabolic Syndrome: 7.9 (2005) (0)
Recent advances in angiotensin-converting enzyme inhibition in the treatment of hypertension and heart failure: Introduction (1993) (0)
NON-INVASIVE CHARACTERIZATION OF CAROTID PLAQUE COMPOSITION BY IBS ANALYSIS: 2B.2 (2004) (0)
Assessment of subclinical organ damage for stratification of total cardiovascular risk (2011) (0)
[Reflex control of the renal secretion of renin]. (1975) (0)
Effects of nitric oxide synthesis inhibition on blood pressure and pulse interval spectral powers (1999) (0)
In Memoriam: Alberto Zanchetti (Parma 27 July 1926–Milan 24 March 2018) (2018) (0)
Arterial Baroreflexes in Human Beings (1984) (0)
CHRONIC BLOCKADE OF CORTICOTROPIN RELEASING HORMONE SECRETION EXERTS SYMPATHOINHIBITORY EFFECTS IN HUMAN OBESITY: 5B.5 (2000) (0)
2.2 Reverse Dipping Blood Pressure Pattern is Characterized by a Marked Adrenergic Overdrive (2008) (0)
10.3 Effects of 2 Years Treatment with Quinapril on Carotid Intima Media in Type 1 Diabetes Mellitus (2007) (0)
EARLY BLOOD PRESSURE CONTROL BY THE NIFEDIPINE GITS/TELMISARTAN COMBINATION: PP.33.314 (2010) (0)
IS BLUNTED HEART RATE DECREASE AT NIGHT ASSOCIATED TO PREVALENT ORGAN DAMAGE IN ESSENTIAL HYPERTENSION?: 1A.02 (2011) (0)
LEFT VENTRICULAR GEOMETRIC PATTERN AND ABPM PROFILE IN THE ELDERLY: PP.4.112 (2011) (0)
Hypertension Online Only (2004) (0)
COMPARATIVE EFFECTIVENESS OF TWO-DRUG THERAPY VERSUS MONOTHERAPY AS INITIAL REGIMEN IN HYPERTENSION: A PROPENSITY-SCORE MATCHED COHORT STUDY IN A LARGE PRIMARY CARE DATABASE (2018) (0)
Blood Pressure Targets with Antihypertensive Treatment (2012) (0)
In the metabolic syndrome adrenergic overdrive is independent on the obese state (2008) (0)
MITRAL DECELERATION INDEX IS ASSOCIATED TO AORTIC ROOT DILATATION AND NOT TO BIVENTRICULAR STRUCTURAL CHANGES IN ESSENTIAL HYPERTENSION: PP.36.201 (2011) (0)
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities (2007) (0)
Response to seasonal changes in blood pressure: possible interaction between sunlight and brain serotonin. (2013) (0)
EFFICACY AND TOLERABILITY OF CANDESARTAN 16 MG + HYDROCHLOROTHIAZIDE 12.5 MG FIXED COMBINATION VS. PREVIOUS MONOTHERAPY + HYDROCHLOROTHIAZIDE IN ESSENTIAL HYPERTENSION (2004) (0)
[Arterial pressure during natural sleep in the cat before and after interruption of the sympathetic and parasympatetic innervation of the heart]. (1967) (0)
Patterns of cardiovascular variability after long-term sino-aortic denervation in unanesthetized adult rats (2019) (0)
TIME COURSE OF DIRECT AND INDIRECT MEASURES OF WHITE COAT EFFECT OVER REPEATED VISITS: P1.147 (2000) (0)
A4699 Effects of renal denervation in patients with versus without chronic kidney disease: results from the Global Symplicity Registry with follow-up data of 3 years (2018) (0)
In memoriam: Peter Sleight 1929–2020 (2020) (0)
RELATIONSHIP BETWEEN NOCTURNAL BLOOD PRESSURE PATTERNS AND DAYTIME BLOOD PRESSURE VARIABILITY IN THE SPANISH AMBULATORY BLOOD PRESSURE MONITORING REGISTRY: 8C.05 (2010) (0)
[Dynamic monitoring of blood pressure for 24 hours. From the research laboratory to clinical practice: problems and perspectives]. (1999) (0)
[OP.1C.12] VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY IS RELATED TO SYMPATHETIC NEURAL DRIVE AND BAROREFLEX SENSITIVITY IN HYPERTENSIVE PATIENTS (2017) (0)
parabolic flight Cardiovascular and Valsalva responses during (2015) (0)
[Renal blood flow during desynchronized sleep in the cat]. (1968) (0)
[Hemodynamic changes during sleep in animals with intact sympathetic system and in sympathetectomized animals]. (1968) (0)
Treatment of resistant hypertension. (2018) (0)
THU0139 Cardiovascular Risk Factor Profile in an Italian Cohort of Patients with Rheumatoid Arthritis: Results of a Three Year Follow-up (2015) (0)
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings (2012) (0)
8.9 Gender-Related Differences in Periodic Breathing During Sleep Under High Altitude Hypoxia (2007) (0)
ALTERATIONS OF RETINAL MICROVASCULAR NETWORK IN THE HIGH-NORMAL BLOOD PRESSURE STATE: EVIDENCE AND MECHANISMS: PP.35.449 (2010) (0)
THE PATTERNS OF THE RETINAL MICROVASCULAR NETWORK ARE NOT RELATED TO THE OVERWEIGHT OR THE OBESE STATE: 1C.03 (2011) (0)
FUNCTIONAL AND STRUCTURAL ALTERATIONS OF COMMON CAROTID ARTERY AND AORTA IN CORONARY ATHEROSCLEROSIS: P1.140 (2004) (0)
Highlights of the September issue. (2018) (0)
Advances in Pathophysiology and Management of Hypertension (1989) (0)
Abstract 10123: Evidence Against the J-shaped Curve in Treated Hypertensive Patients With Increased Cardiovascular Risk: The VALUE Trial (2015) (0)
[Hemodynamic changes during fighting behavior in cats. II. Fighting in lying-down position]. (1968) (0)
443 PROGNOSTIC VALUE OF “PARTIAL” AND “TRUE” WHITE COAT HYPERTENSION: DATA FROM 16 YEAR FOLLOW–UP IN THE PAMELA POPULATION (2012) (0)
Highlights from this issue (2018) (0)
Update the set of principles and beliefs. Authors' reply (2008) (0)
Blood pressure variability and cardiovascular risk in 9 eastern european countries: data from the BP-Care study (2015) (0)
RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF DRUG-RESISTANT HYPERTENSION IN AN ASIAN POPULATION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY IN SOUTH KOREA (GSR KOREA) AND COMPARISON TO SYMPLICITY HTN-2 (2015) (0)
[Antihypertensive therapy: why and how?]. (1997) (0)
Erratum: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities [High Blood Press Cardiovasc Prev, (2014), 21, (29-36), DOI 10.1007/s40292-013-0034-z] (2015) (0)
Chronic Coronary Artery Disease Predictors of Adverse Outcome Among Patients With Hypertension and Coronary Artery Disease (2006) (0)
[BP.02.05] FEASIBILITY AND EFFICACY OF RENAL DENERVATION THERAPY IN HEMODIALYSIS PATIENTS WITH RESISTANT HYPERTENSION. (2017) (0)
[Dynamic monitoring of arterial pressure in the diagnosis of hypertension: problems and perspectives]. (1990) (0)
[Clinical aspects of the neurogenic control of circulation in arterial hypertension]. (1979) (0)
Background, history and epidemiology (2008) (0)
5.5 Prevalence and Correlates of Multiple Organ Damage in Treated Hypertensives: Results From the ETODH Study (2008) (0)
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure (2021) (0)
HIGH NORMAL BLOOD PRESSURE AND ABNORMAL LEFT VENTRICULAR GEOMETRIC PATTERNS (2019) (0)
THE IRON-HYPOXIA LINK: HEPCIDIN HAS A CENTRAL ROLE IN THE RESPONSE TO ACUTE AND CHRONIC EXPOSURE TO HYPOBARIC HYPOXIA. DATA FROM THE HIGHCARE PROJECT: PP.12.453 (2010) (0)
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma]. (1981) (0)
Highlights of the April issue. (2020) (0)
42 Sympathetic mechanisms and mid- to low-frequency blood pressure spectral powers: studies in conscious sympathectomized rats (1993) (0)
Evaluation Of Neural Cardiovascular Control Through Dynamic Analysis Of 24 Hour Blood Pressure And Heart Rate (1990) (0)
Changes in Albuminuria and the Risk ofMajor (2017) (0)
2.4 White Coat and Masked Hypertension Increase the Risk of New Onset Sustained Hypertension in the General Population (2008) (0)
[The intervention trial in the evaluation of antihypertensive therapy]. (1995) (0)
Book review (2005) (0)
Different determinants of left ventricular mass and relative wall thickness in male and female hypertensive patients undergoing 24 hour ambulatory blood pressure monitoring (2005) (0)
ESH statement on detection and punishment of abstract fraud and poster plagiarism. (2006) (0)
PS-P07-9: USE OF INITIAL AND SUBSEQUENT ANTIHYPERTENSIVE COMBINATION TREATMENT IN THE CLINICAL PRACTICE. EVIDENCE FROM A POPULATION-BASED INVESTIGATION IN ITALY (2023) (0)
Comprar Resistant Hypertension | Giuseppe Mancia | 9788847054141 | Springer (2013) (0)
Predicting the 20-year risk of first coronary or ischemic stroke event in Northern Italy: the CAMUNI absolute risk equation (2013) (0)
A-33 | Clinical Event Reductions in Younger Vs. OLDER Hypertension Patients treated with Radiofrequency Renal Denervation: 10-Year Projections based on 3-Year Follow-up from the Global SYMPLICITY Registry (2022) (0)
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study (2011) (0)
4.2 Echographic Evaluation of Cardiac Toxicity and Tissue Characterization After Anthracycline Chemotherapy in Childhood: The Importance of Fractional Shortening (FS) (2007) (0)
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?]. (1981) (0)
PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION: AN UP-DATED ANALYSIS OF ECHOCARDIOGRAPHIC STUDIES: 3D.02 (2011) (0)
Interferon monotherapy revisited: Role of genotypes and of effective management of breakthrough in long term response in chronic hepatitis C patients (2001) (0)
P12.03: RELATIONSHIP OF COMMON CAROTID ARTERY WAVE INTENSITY WITH AGE AND SEX IN HEALTHY NORMOTENSIVE PEOPLE RELATIONSHIP OF COMMON CAROTID ARTERY WAVE INTENSITY WITH AGE AND SEX IN HEALTHY NORMOTENSIVE PEOPLE, (0)
Prevalence, awareness, treatment, and control of hypertension in the elderly : the Three City study. Commentary (2006) (0)
Highlights of the November issue. (2020) (0)
The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus (2013) (0)
Impaired Autonomic Blood Pressure and Blood Volume Control in Chronic Renal Failure (2010) (0)
[Hemodynamic changes during natural urination in the cat]. (1968) (0)
, Transplantation in Humans Arterial Stiffening Influence of Sympathetic Nerve Activity : Evidence From Hand (2005) (0)
Baroreceptor mechanisms and the control of vascular resistance (1989) (0)
INAPPROPRIATE LEFT VENTRICULAR MASS IS ASSOCIATED WITH VASCULAR ORGAN DAMAGE INDEPENDENTLY ON LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION: 3B.05 (2011) (0)
Dynamic Evaluation of Neural Cardiovascular Regulation Through the Analysis of Blood Pressure and Pulse Interval Variability over 24 Hours (1992) (0)
G65Evaluation of blood pressure changes in post myocardial infarction patients undergoing physical training. preliminary data (1995) (0)
DEMOGRAPHIC, ANTHROPOMETRIC, HAEMODYNAMIC AND METABOLIC DETERMINANTS OF LEFT ATRIAL SIZE IN THE GENERAL POPULATION: DATA FROM THE PAMELA STUDY: 5A.03 (2011) (0)
SUSTAINED SYMPATHOINHIBITORY EFFECTS OF CARDIAC RESYNCHRONIZATION THERAPHY IN HEART FAILURE: P3.49 (2004) (0)
SUBGROUP ANALYSIS IN THE GLOBAL SYMPLICITY REGISTRY (2019) (0)
[Hemodynamic mechanisms of arterial hypotension present during desynchoronized sleep in the cat]. (1967) (0)
Respiratory patterns and baroreflex function in heart failure (2023) (0)
MxA mRNA as early predicter of response to interferon therapy in chronic hepatitis C (1998) (0)
PP.07.22: COMPARISON OF A NEW FIRST-LINE SINGLE-PILL ANTIHYPERTENSIVE STRATEGY WITH A STEPPED-CARE STRATEGY USING THE TIME TO BLOOD PRESSURE CONTROL (2015) (0)
PROGNOSTIC VALUE OF CLINIC, HOME AND AMBULATORY PULSE PRESSURE IN THE GENERAL POPULATION. DATA FROM THE PAMELA STUDY (2018) (0)
IMPACT OF BODY MASS INDEX AND WAIST CIRCUMFERENCE ON THE RISK OF CARDIOVASCULAR EVENTS AND ALL-CAUSE DEATH IN A GENERAL POPULATION: PP.7.283 (2010) (0)
[Vasomotor changes in the superior mesenteric region in response to local reductions of flow]. (1969) (0)
SaO002ASYMMETRIC (ADMA) AND SYMMETRIC (SDMA) DIMETHYLARGININE AND SYMPATHETIC NERVE TRAFFIC AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: A LONGITUDINAL STUDY (2015) (0)
Reply to Editorial (1997) (0)
CORRELATION BETWEEN LEFT VENTRICULAR MASS (LVM) AND AMBULATORY OR CLINIC BLOOD PRESSURE (BP) IN VERY ELDERLY SUBJECTS: PP.22.351 (2010) (0)
[PP.16.07] CVD RISK IS INDEPENDENTLY ASSOCIATED WITH VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE (BP) IN PATIENTS WITH TYPE 2 DIABETES (2017) (0)
[Alpha-methyldopa and neural control of the circulation in essential hypertension]. (1980) (0)
Combined effects of changes in blood pressure nocturnal dip and of drug treatment on the ambulatory artery stiffness index (2007) (0)
4.4 Ambulatory Heart Rate and Target Organ Damage in Never Treated Essential Hypertensives (2007) (0)
52 Effects of ageing on the different spectral components of twenty-four-hour blood pressure and pulse interval variability in humans (1993) (0)
Blood pressure analyses from 25 595 patients (from 25 620 randomised) during the ONTARGET trial: reflections on current guidelines (2008) (0)
Evaluation of central and reflex cardiovascular control by beat-to-beat analysis of the 24 hour blood pressure signal in man. (1988) (0)
Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 2. How to manage high blood pressure in children and adolescents (2023) (0)
[History and significance of guidelines in cardiology: the example of arterial hypertension]. (1999) (0)
1.8 Impact of Overweight on Nocturnal Blood Pressure Patterns in Untreated Essential Hypertensives (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giuseppe Mancia?

Giuseppe Mancia is affiliated with the following schools:

Giuseppe Mancia's Academic­Influence.com Rankings

Why Is Giuseppe Mancia Influential?

Giuseppe Mancia's Published Works

Published Works

What Schools Are Affiliated With Giuseppe Mancia?

Giuseppe Mancia's AcademicInfluence.com Rankings